JPH085866B2 - Novel aconitine compounds and analgesic / anti-inflammatory agents - Google Patents
Novel aconitine compounds and analgesic / anti-inflammatory agentsInfo
- Publication number
- JPH085866B2 JPH085866B2 JP62301221A JP30122187A JPH085866B2 JP H085866 B2 JPH085866 B2 JP H085866B2 JP 62301221 A JP62301221 A JP 62301221A JP 30122187 A JP30122187 A JP 30122187A JP H085866 B2 JPH085866 B2 JP H085866B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- analysis
- ethyl
- methyl
- benzoyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000000202 analgesic effect Effects 0.000 title claims description 14
- 239000000730 antalgic agent Substances 0.000 title claims description 6
- 239000002260 anti-inflammatory agent Substances 0.000 title claims description 6
- 229940121363 anti-inflammatory agent Drugs 0.000 title claims description 6
- 150000002952 aconitine derivatives Chemical class 0.000 title description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 93
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 67
- -1 aconitine compound Chemical class 0.000 claims description 27
- 239000001257 hydrogen Substances 0.000 claims description 26
- 229910052739 hydrogen Inorganic materials 0.000 claims description 26
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 22
- XFSBVAOIAHNAPC-UHFFFAOYSA-N Aconitin Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-UHFFFAOYSA-N 0.000 claims description 21
- 229940039750 aconitine Drugs 0.000 claims description 21
- STDXGNLCJACLFY-UHFFFAOYSA-N aconitine Natural products CCN1CC2(COC)C(O)CC(O)C34C5CC6(O)C(OC)C(O)C(OC(=O)C)(C5C6OC(=O)c7ccccc7)C(C(OC)C23)C14 STDXGNLCJACLFY-UHFFFAOYSA-N 0.000 claims description 21
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 18
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 16
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 claims description 9
- 150000002431 hydrogen Chemical class 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 178
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 108
- 238000004458 analytical method Methods 0.000 description 98
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 90
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 80
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 72
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 72
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 69
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 66
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 52
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 48
- 238000000862 absorption spectrum Methods 0.000 description 48
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 48
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 45
- 238000006243 chemical reaction Methods 0.000 description 40
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 36
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 34
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 33
- 239000002904 solvent Substances 0.000 description 32
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 30
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 27
- 239000000243 solution Substances 0.000 description 27
- 239000000203 mixture Substances 0.000 description 25
- 239000000843 powder Substances 0.000 description 25
- 238000010898 silica gel chromatography Methods 0.000 description 25
- 238000010521 absorption reaction Methods 0.000 description 24
- 238000001819 mass spectrum Methods 0.000 description 24
- 230000000704 physical effect Effects 0.000 description 24
- 235000011114 ammonium hydroxide Nutrition 0.000 description 23
- 235000019439 ethyl acetate Nutrition 0.000 description 23
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 20
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 19
- XFSBVAOIAHNAPC-XTHSEXKGSA-N 16-Ethyl-1alpha,6alpha,19beta-trimethoxy-4-(methoxymethyl)-aconitane-3alpha,8,10alpha,11,18alpha-pentol, 8-acetate 10-benzoate Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-XTHSEXKGSA-N 0.000 description 17
- XUHJBXVYNBQQBD-UHFFFAOYSA-N mesaconitine Natural products COC1CC(O)C2(COC)CN(C)C3C(C(C45)(OC(C)=O)C(O)C6OC)C(OC)C2C31C4CC6(O)C5OC(=O)C1=CC=CC=C1 XUHJBXVYNBQQBD-UHFFFAOYSA-N 0.000 description 17
- 239000003921 oil Substances 0.000 description 15
- 235000019198 oils Nutrition 0.000 description 15
- 150000001875 compounds Chemical class 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- XUHJBXVYNBQQBD-GQPWXMLZSA-N molport-002-525-145 Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@]45[C@@H]6[C@@H](OC)[C@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H]4N(C)C[C@@]6([C@@H](C[C@@H]5OC)O)COC)C(=O)C1=CC=CC=C1 XUHJBXVYNBQQBD-GQPWXMLZSA-N 0.000 description 12
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 229910052938 sodium sulfate Inorganic materials 0.000 description 9
- 235000011152 sodium sulphate Nutrition 0.000 description 9
- MGTJNQWIXFSPLC-HQARQGIISA-N Jesaconitine Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=C(OC)C=C1 MGTJNQWIXFSPLC-HQARQGIISA-N 0.000 description 7
- MGTJNQWIXFSPLC-UHFFFAOYSA-N jesaconitine Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=C(OC)C=C1 MGTJNQWIXFSPLC-UHFFFAOYSA-N 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical class [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 6
- DPMGVDIWDTYPMP-UHFFFAOYSA-N Hypaconitine Natural products COCC12CCC(OC)C3(CN(C)C1)C4CC5(O)C(OC)C(O)C(CC(OC)C23)(OC(=O)C)C4C5OC(=O)c6ccccc6 DPMGVDIWDTYPMP-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- FIDOCHXHMJHKRW-GKVQVCCJSA-N hypaconitine Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@]45[C@@H](OC)CC[C@@]6([C@H]4[C@@H](OC)[C@H]([C@@](OC(C)=O)([C@H]31)[C@@H](O)[C@H]2OC)[C@H]5N(C)C6)COC)C(=O)C1=CC=CC=C1 FIDOCHXHMJHKRW-GKVQVCCJSA-N 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 235000010418 carrageenan Nutrition 0.000 description 4
- 229920001525 carrageenan Polymers 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000004949 mass spectrometry Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- RNHDAKUGFHSZEV-UHFFFAOYSA-N 1,4-dioxane;hydrate Chemical compound O.C1COCCO1 RNHDAKUGFHSZEV-UHFFFAOYSA-N 0.000 description 3
- 244000215068 Acacia senegal Species 0.000 description 3
- 229920000084 Gum arabic Polymers 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 235000010489 acacia gum Nutrition 0.000 description 3
- 239000000205 acacia gum Substances 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- DHJXZSFKLJCHLH-BMTFSNIDSA-N 369u7a6hxd Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45[C@H]6[C@@H]([C@@]([C@H]31)(O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 DHJXZSFKLJCHLH-BMTFSNIDSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 230000021736 acetylation Effects 0.000 description 2
- 238000006640 acetylation reaction Methods 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- DHJXZSFKLJCHLH-UHFFFAOYSA-N benzoylaconine Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 DHJXZSFKLJCHLH-UHFFFAOYSA-N 0.000 description 2
- PULWZCUZNRVAHT-LOCDBSKESA-N benzoylmesaconine Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@]45[C@@H]6[C@@H](OC)[C@H]([C@@]([C@H]31)(O)[C@@H](O)[C@@H]2OC)[C@H]4N(C)C[C@@]6([C@@H](C[C@@H]5OC)O)COC)C(=O)C1=CC=CC=C1 PULWZCUZNRVAHT-LOCDBSKESA-N 0.000 description 2
- PULWZCUZNRVAHT-UHFFFAOYSA-N benzoylmesaconine Natural products COC1CC(O)C2(COC)CN(C)C3C(C(C45)(O)C(O)C6OC)C(OC)C2C31C4CC6(O)C5OC(=O)C1=CC=CC=C1 PULWZCUZNRVAHT-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 231100001231 less toxic Toxicity 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- OKZRRYTYGSMPAD-SHANDMFISA-N 14-anisoylaconine Chemical compound O([C@H]1[C@]2(O)C[C@H]3C45C6C([C@@]([C@H]31)(O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=C(OC)C=C1 OKZRRYTYGSMPAD-SHANDMFISA-N 0.000 description 1
- 241000173529 Aconitum napellus Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 235000006089 Phaseolus angularis Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 1
- 240000007098 Vigna angularis Species 0.000 description 1
- 235000010711 Vigna angularis Nutrition 0.000 description 1
- 239000012345 acetylating agent Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- PULWZCUZNRVAHT-IJNXHYLPSA-N benzoylmesaconine Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@]45[C@@H]6[C@@H](OC)[C@H]([C@@]([C@H]31)(O)[C@@H](O)[C@@H]2OC)C4N(C)C[C@@]6([C@@H](C[C@@H]5OC)O)COC)C(=O)C1=CC=CC=C1 PULWZCUZNRVAHT-IJNXHYLPSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- GQRPJUIKGLHLLN-VSTHTWNCSA-N mesaconine Chemical compound COC[C@]12CN(C)C3[C@@H]4[C@H](OC)[C@H]1[C@]3([C@@H]1C[C@@]3(O)[C@H](O)[C@@H]1[C@]4(O)[C@@H](O)[C@@H]3OC)[C@H](C[C@H]2O)OC GQRPJUIKGLHLLN-VSTHTWNCSA-N 0.000 description 1
- 239000010446 mirabilite Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Landscapes
- Other In-Based Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
【発明の詳細な説明】 本発明は新規なアコニチン系化合物および鎮痛・抗炎
症剤に関するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel aconitine compound and an analgesic / anti-inflammatory agent.
さらに詳しく言えば、本発明は一般式 (式中、R1はベンゾイル又はアニソイル、R2はメチル又
はエチル、R3は水酸基、アセチルオキシ又は水素、R4は
低級アルキル基又は水素を表す。但し、R1がベンゾイ
ル、R2がエチル、R3がアセチルオキシである場合はR4は
エチルではない。R1がベンゾイル、R2がメチル、R3が水
酸基である場合はR4はメチル、エチル又は水素ではな
い。R1がアニソイル、R2がエチル、R3が水酸基の場合は
R4はメチル、エチル又は水素ではない。R1がベンゾイ
ル、R2がメチル、R3が水素の場合はR4は水素ではない。
R1がベンゾイル、R2がエチル、R3が水酸基の場合はR4は
水素ではない。) で表される新規なアコニチン系化合物および一般式 (式中、R1はベンゾイル又はアニソイル、R2はメチル又
はエチル、R3は水酸基、アセチルオキシ又は水素、R4は
低級アルキル基又は水素を表す。但し、R1がベンゾイ
ル、R2がメチル又はエチル、R3が水酸基である場合はR4
は水素ではない。R1がベンゾイル、R2がメチル、R3が水
素である場合はR4は水素ではない。R1がアニソイル、R2
がエチル、R3が水酸基の場合はR4は水素ではない。) で表される化合物を有効成分として含有する鎮痛・抗炎
症剤に関するものである。More specifically, the invention has the general formula (In the formula, R 1 represents benzoyl or anisoyl, R 2 represents methyl or ethyl, R 3 represents a hydroxyl group, acetyloxy or hydrogen, R 4 represents a lower alkyl group or hydrogen, provided that R 1 is benzoyl and R 2 is ethyl. , R 3 is acetyloxy, R 4 is not ethyl R 1 is benzoyl, R 2 is methyl and R 3 is a hydroxyl group R 4 is not methyl, ethyl or hydrogen R 1 is anisoyl , R 2 is ethyl and R 3 is a hydroxyl group,
R 4 is not methyl, ethyl or hydrogen. R 4 is not hydrogen when R 1 is benzoyl, R 2 is methyl and R 3 is hydrogen.
R 4 is not hydrogen when R 1 is benzoyl, R 2 is ethyl and R 3 is a hydroxyl group. ) A novel aconitine compound represented by (In the formula, R 1 represents benzoyl or anisoyl, R 2 represents methyl or ethyl, R 3 represents a hydroxyl group, acetyloxy or hydrogen, R 4 represents a lower alkyl group or hydrogen, provided that R 1 is benzoyl and R 2 is methyl. Or ethyl, R 4 when R 3 is a hydroxyl group
Is not hydrogen. R 4 is not hydrogen when R 1 is benzoyl, R 2 is methyl and R 3 is hydrogen. R 1 is Anisoyl, R 2
Is ethyl and R 3 is a hydroxyl group, R 4 is not hydrogen. ) The present invention relates to an analgesic / anti-inflammatory agent containing a compound represented by
トリカブト属植物の塊根に含まれるアコニチン系アル
カロイド物質が強力な鎮痛作用および抗炎症作用を有す
ることは既に報告されている。しかし,アコニチン系ア
ルカロイド物質は毒性が強く,したがつて,安全域が狭
いとされていた。It has already been reported that the aconitine-based alkaloid substances contained in tuberous roots of aconite plants have strong analgesic and anti-inflammatory effects. However, aconitine alkaloids are highly toxic, and therefore, the safety margin is said to be narrow.
本発明者は,アコニチン系アルカロイド物質の有する
鎮痛・抗炎症作用を保持し,かつ毒性の低い新規なアコ
ニチン系アルカロイド誘導体を得るべく種々研究を行つ
た結果,本発明により,前記一般式(II)で表される化
合物を提供することに成功した。本発明に係る物質は強
力な鎮痛・抗炎症活性を有し,さらに母体のメサコニチ
ン,アコニチン,ヒパコニチンおよびジェサコニチンよ
りも低毒性であることが見い出された。The present inventor has conducted various studies to obtain a novel aconitine alkaloid derivative having an analgesic / anti-inflammatory action possessed by an aconitine alkaloid substance and having low toxicity. As a result, according to the present invention, the above general formula (II) We have succeeded in providing a compound represented by. It has been found that the substance according to the present invention has a strong analgesic / anti-inflammatory activity and is less toxic than maternal mesaconitine, aconitine, hipaconitine and jesaconitine.
本発明は,かかる知見に基づくものである。したがっ
て,本発明は前記一般式(I)で表される新規な化合物
および前記一般式(II)で表される化合物を含有する鎮
痛・抗炎症剤を提供するものである。The present invention is based on such findings. Therefore, the present invention provides a novel compound represented by the general formula (I) and an analgesic / anti-inflammatory agent containing the compound represented by the general formula (II).
本発明に係る前記の式(II)で表される化合物は,下
記式(III)で表されるメサコニチン,下記式(IV)で
表されるアコニチン又は下記式(V)で表されるジェサ
コニチンの3位水酸基を常法によりアセチル化し,また
下記式(III),(IV),(V)および(VI)で表され
るヒパコニチンの8位のアセチルオキシ基を低級アルコ
キシ基に置換するか,あるいは加水分解することにより
製造することができる。The compound represented by the above formula (II) according to the present invention includes a mesaconitine represented by the following formula (III), an aconitine represented by the following formula (IV) or a gesaconitine represented by the following formula (V). The 3-position hydroxyl group is acetylated by a conventional method, and the 8-position acetyloxy group of the hypaconitine represented by the following formulas (III), (IV), (V) and (VI) is substituted with a lower alkoxy group, or It can be produced by hydrolysis.
上記のアセチル化にあたつては,通常,化学構造中に
存在する水酸基をアセチルオキシ基(酢酸エステル)に
変換するために採択される化学的手段を任意に使用する
ことができる。例えば,適当な溶媒を選択使用し,その
溶媒中で上記のメサコニチン,アコニチンあるいはジェ
サコニチンとアセチル化剤例えば無水酢酸とを反応せし
めて上記のアセチル化を行うことができる。また、8位
のアセチルオキシ基と低級アルコキシ基との置換は、対
応する低級アルコール、例えばメタノール、エタノー
ル、プロパノール、イソプロパノール、ブタノール、t-
ブタノール、アミルアルコールを溶媒として用い行なう
ことができる。 In the above-mentioned acetylation, a chemical means usually adopted for converting a hydroxyl group usually present in a chemical structure into an acetyloxy group (acetic ester) can be optionally used. For example, the above-mentioned acetylation can be carried out by selecting and using an appropriate solvent and reacting the above-mentioned mesaconitine, aconitine or jesaconitine with an acetylating agent such as acetic anhydride. Further, the substitution of the acetyloxy group at the 8-position with the lower alkoxy group is carried out by using the corresponding lower alcohol such as methanol, ethanol, propanol, isopropanol, butanol, t-
Butanol and amyl alcohol can be used as a solvent.
以下に,本発明に係る化合物の製造実施例を掲げる。
また,各実施例で得られた化合物の物性値,分析デー
タ,薬理作用,毒性,その他については後に掲げる。The production examples of the compound according to the present invention are listed below.
The physical properties of the compounds obtained in each example, analytical data, pharmacological action, toxicity, etc. will be given later.
なお、製造実施例中に記載されたシリカゲルカラムク
ロマトグラフィーはMerck.Art 7734 Kieselgel 60(70
〜230 mesh)を用いて行った。In addition, the silica gel column chromatography described in the production examples is based on Merck. Art 7734 Kieselgel 60 (70
~ 230 mesh).
[実施例1] アコニチン180mgをメタノール30mlに溶解し、油浴温
度60〜70℃で30時間攪拌する。反応終了後、反応液を減
圧下濃縮し、残留物はシリカゲルカラムクロマトグラフ
ィー(溶媒:アンモニア水飽和エーテル)で分離、精製
し8−O−メチル−14−ベンゾイルアコニン127.6mg
(収率72%)を得る。[Example 1] 180 mg of aconitine is dissolved in 30 ml of methanol and stirred at an oil bath temperature of 60 to 70 ° C for 30 hours. After completion of the reaction, the reaction solution was concentrated under reduced pressure, and the residue was separated and purified by silica gel column chromatography (solvent: ammonia water saturated ether) and purified with 8-O-methyl-14-benzoylaconine 127.6 mg.
(Yield 72%) is obtained.
[実施例2] アコニチン103mgをエタノール10mlに溶解し、油浴温
度70−80℃で64時間攪拌する。反応終了後、反応液を減
圧下濃縮し、残留物はシリカゲルカラムクロマトグラフ
ィー(溶媒:アンモニア水飽和エーテル)で分離、精製
し8−O−メチル−14−ベンゾイルアコニン71.6mg(収
率71%)を得る。[Example 2] Aconitine (103 mg) was dissolved in ethanol (10 ml), and the mixture was stirred at an oil bath temperature of 70 to 80 ° C for 64 hours. After completion of the reaction, the reaction solution was concentrated under reduced pressure, and the residue was separated and purified by silica gel column chromatography (solvent: ammonia water saturated ether) and purified to give 8-O-methyl-14-benzoylaconine 71.6 mg (yield 71% ) Get.
[実施例3] アコニチン331mgにピリジン8mlと無水酢酸30mlを加え
室温で16時間攪拌する。反応液を減圧下濃縮乾固し、残
留物をクロロホルム50mlに溶かし、クロロホルム層は5
%NaHCO3水溶液ついで水で洗浄後、芒硝で乾燥し、減圧
下留去する。残留物はシリカゲルカラムクロマトグラフ
ィー(溶媒:アンモニア水飽和エーテル)で分離、精製
し、3−O−アセチルアコニチン300.9mgを得る(収率8
5.3%)。3−O−アセチルアコニチン100.5mgをメタノ
ール10mlに溶解し、油浴温度70−80℃で87時間攪拌す
る。反応終了後、反応液を減圧下濃縮し、残留物はシリ
カゲルカラムクロマトグラフィー(溶媒:アンモニア水
飽和エーテル)で分離、精製し3−O−アセチル−8−
O−メチル−14−ベンゾイルアコニン75mg(収率73%)
を得る。Example 3 To 331 mg of aconitine, 8 ml of pyridine and 30 ml of acetic anhydride were added, and the mixture was stirred at room temperature for 16 hours. The reaction mixture was concentrated to dryness under reduced pressure, the residue was dissolved in 50 ml of chloroform, and the chloroform layer was mixed with 5 ml.
% NaHCO 3 aqueous solution and then washed with water, dried over sodium sulfate, and evaporated under reduced pressure. The residue is separated and purified by silica gel column chromatography (solvent: ammonia water saturated ether) to obtain 300.9 mg of 3-O-acetylaconitine (yield 8
5.3%). 100.5 mg of 3-O-acetylaconitine is dissolved in 10 ml of methanol and stirred at an oil bath temperature of 70-80 ° C for 87 hours. After completion of the reaction, the reaction solution was concentrated under reduced pressure, and the residue was separated and purified by silica gel column chromatography (solvent: ammonia water saturated ether) and purified to 3-O-acetyl-8-.
75 mg of O-methyl-14-benzoyl aconine (yield 73%)
To get
[実施例4] 実施例3において用いたメタノール(10ml)の代わり
にエタノール(10ml)を用いて、他は実施例3と全く同
様に行ない3−O−アセチル−8−O−エチル−14−ベ
ンゾイルアコニン71mg(収率72%)を得る。Example 4 The procedure of Example 3 was repeated except that ethanol (10 ml) was used instead of methanol (10 ml) used in Example 3, and 3-O-acetyl-8-O-ethyl-14- was used. 71 mg (72% yield) of benzoyl aconine are obtained.
[実施例5] アコニチン331mgにピリジン8mlと無水酢酸30mlを加え
室温で16時間かくはんする。反応液を減圧下濃縮乾固
し、残留物をクロロホルム50mlに溶かし、クロロホルム
層は5%NaHCO3水溶液ついで水で洗浄後、芒硝で乾燥
し、減圧下留去する。残留物はシリカゲルカラムクロマ
トグラフィー(溶媒:アンモニア水飽和エーテル)で分
離、精製し、3−O−アセチルアコニチン300.9mgを得
る(収率85.3%)。3−O−アセチルアコニチン100mg
をジオキサン−水(1:1)混液10ml中で4時間加熱還流
する。反応終了後、溶媒を減圧下留去する。得られた残
留物をカラムクロマトあるいは薄層クロマトグラフィー
(溶媒:アンモニア水飽和エーテル)で分離、精製し3
−O−アセチル−14−ベンゾイルアコニン78mg(収率83
%)を得る。Example 5 8 ml of pyridine and 30 ml of acetic anhydride were added to 331 mg of aconitine, and the mixture was stirred at room temperature for 16 hours. The reaction solution is concentrated to dryness under reduced pressure, the residue is dissolved in 50 ml of chloroform, the chloroform layer is washed with a 5% NaHCO 3 aqueous solution and then with water, dried over sodium sulfate and evaporated under reduced pressure. The residue is separated and purified by silica gel column chromatography (solvent: ammonia water saturated ether) to obtain 300.9 mg of 3-O-acetylaconitine (yield 85.3%). 3-O-acetylaconitine 100mg
Is heated to reflux in 10 ml of a dioxane-water (1: 1) mixture for 4 hours. After completion of the reaction, the solvent is distilled off under reduced pressure. The obtained residue is separated and purified by column chromatography or thin layer chromatography (solvent: ammonia water saturated ether).
78 mg of -O-acetyl-14-benzoylaconine (yield 83
%).
[実施例6] メサコニチン300mgをメタノール180mlに溶解し、油浴
温度60〜70℃で168時間攪拌する。反応終了後、反応液
を減圧下濃縮し、残留物はシリカゲルカラムクロマトグ
ラフィー(溶媒:アンモニア水飽和エーテル)で分離、
精製し8−O−メチル−14−ベンゾイルメサコニン280m
g(収率97.6%)を得る。[Example 6] 300 mg of mesaconitine is dissolved in 180 ml of methanol, and the mixture is stirred at an oil bath temperature of 60 to 70 ° C for 168 hours. After the reaction was completed, the reaction solution was concentrated under reduced pressure, and the residue was separated by silica gel column chromatography (solvent: ammonia water saturated ether),
Purified 8-O-methyl-14-benzoyl mesaconine 280 m
g (yield 97.6%) is obtained.
[実施例7] メサコニチン300mgをエタノール180mlに溶解し、油浴
温度60〜70℃で240時間攪拌する。反応終了後、反応液
を減圧下濃縮し、残留物はシリカゲルカラムクロマトグ
ラフィー(溶媒:アンモニア水飽和エーテル)で分離、
精製し8−O−メチル−14−ベンゾイルメサコニン285m
g(収率97%)を得る。Example 7 300 mg of mesaconitine is dissolved in 180 ml of ethanol, and the mixture is stirred at an oil bath temperature of 60 to 70 ° C. for 240 hours. After the reaction was completed, the reaction solution was concentrated under reduced pressure, and the residue was separated by silica gel column chromatography (solvent: ammonia water saturated ether),
Purified 8-O-methyl-14-benzoyl mesaconine 285m
g (97% yield) are obtained.
[実施例8] メサコニチン408mgにピリジン8mlと無水酢酸30mlを加
え室温で16時間攪拌する。反応液を減圧下濃縮乾固し、
残留物をクロロホルム50mlに溶かし、クロロホルム層は
5%NaHCO3水溶液ついで水で洗浄後、芒硝で乾燥し、減
圧下留去する。残留物はシリカゲルカラムクロマトグラ
フィー(溶媒:アンモニア水飽和エーテル)で分離、精
製し、3-O-アセチルメサコニチン400.6mgを得る(収率9
5%) 3−O−アセチルメサコニチン131.0mgをメタノール1
0mlに溶解し、油浴温度70〜80℃で39時間攪拌する。反
応終了後、反応液を減圧下濃縮し、残留物はシリカゲル
カラムクロマトグラフィー(溶媒:アンモニア水飽和エ
ーテル)で分離、精製し3-O-アセチル‐8-O-メチル‐14
−ベンゾイルメサコニン87.9mg(収率70%)を得る。Example 8 To 408 mg of mesaconitine was added 8 ml of pyridine and 30 ml of acetic anhydride, and the mixture was stirred at room temperature for 16 hours. The reaction solution is concentrated to dryness under reduced pressure,
The residue is dissolved in 50 ml of chloroform, and the chloroform layer is washed with a 5% aqueous NaHCO 3 solution and then with water, dried over sodium sulfate and evaporated under reduced pressure. The residue is separated and purified by silica gel column chromatography (solvent: ammonia water saturated ether) to obtain 400.6 mg of 3-O-acetyl mesaconitine (yield 9
5%) 3-O-acetyl mesaconitine 131.0 mg in methanol 1
Dissolve in 0 ml and stir at an oil bath temperature of 70-80 ° C for 39 hours. After the reaction was completed, the reaction solution was concentrated under reduced pressure, and the residue was separated and purified by silica gel column chromatography (solvent: ammonia water saturated ether) and purified with 3-O-acetyl-8-O-methyl-14.
87.9 mg (70% yield) of benzoyl mesaconine are obtained.
[実施例9] メサコニチン408mgにピリジン8mlと無水酢酸30mlを加
え室温で16時間攪拌する。反応液を減圧下濃縮乾固し、
残留物をクロロホルム50mlに溶かし、クロロホルム層は
5%NaHCO3水溶液ついで水で洗浄後、芒硝で乾燥し、減
圧下留去する。残留物はシリカゲルカラムクロマトグラ
フィー(溶媒:アンモニア水飽和エーテル)で分離、精
製し、3-O-アセチルメサコニチン400.6mgを得る(収率9
5%)。3-O-アセチルメサコニチン136.0mgをエタノール
10mlに溶解し、油浴温度70-80℃で87時間攪拌する。反
応終了後、反応液を減圧下濃縮し、残留物はシリカゲル
カラムクロマトグラフィー(溶媒:アンモニア水飽和エ
ーテル)で分離、精製し3-O-アセチル‐8-O-エチル‐14
-ベンゾイルメサコニン98.2mg(収率74%)を得る。[Example 9] 8 ml of pyridine and 30 ml of acetic anhydride were added to 408 mg of mesaconitine, and the mixture was stirred at room temperature for 16 hours. The reaction solution is concentrated to dryness under reduced pressure,
The residue is dissolved in 50 ml of chloroform, and the chloroform layer is washed with a 5% aqueous NaHCO 3 solution and then with water, dried over sodium sulfate and evaporated under reduced pressure. The residue is separated and purified by silica gel column chromatography (solvent: ammonia water saturated ether) to obtain 400.6 mg of 3-O-acetyl mesaconitine (yield 9
Five%). 3-O-Acetylmethaconitine 136.0 mg in ethanol
Dissolve in 10 ml and stir at an oil bath temperature of 70-80 ° C for 87 hours. After the reaction was completed, the reaction solution was concentrated under reduced pressure, and the residue was separated and purified by silica gel column chromatography (solvent: ammonia water saturated ether) and purified to 3-O-acetyl-8-O-ethyl-14.
-Getting 98.2 mg of benzoyl mesaconine (74% yield).
[実施例10] メサコニチン408mgにピリジン8mlと無水酢酸30mlを加
え室温で16時間攪拌する。反応液を減圧下濃縮乾固し、
残留物をクロロホルム50mlに溶かし、クロロホルム層は
5%NaHCO3水溶液ついで水で洗浄後、芒硝で乾燥し、減
圧下留去する。残留物はシリカゲルカラムクロマトグラ
フィー(溶媒:アンモニア水飽和エーテル)で分離、精
製し、3-O-アセチルメサコニチン400.6mgを得る(収率9
5%)。3−O−アセチルメサコニチン100mgをジオキサ
ン−水(1:1)混液10ml中で4時間加熱還流する。反応
終了後、溶媒を減圧下留去する。得られた残留物をカラ
ムクロマトあるいは薄層クロマトグラフィー(溶媒:ア
ンモニア水飽和エーテル)で分離、精製し3−O−アセ
チル−14−ベンゾイルメサコニン77.8mg(収率83%)を
得る。[Example 10] To 408 mg of mesaconitine, 8 ml of pyridine and 30 ml of acetic anhydride were added, and the mixture was stirred at room temperature for 16 hours. The reaction solution is concentrated to dryness under reduced pressure,
The residue is dissolved in 50 ml of chloroform, and the chloroform layer is washed with a 5% aqueous NaHCO 3 solution and then with water, dried over sodium sulfate and evaporated under reduced pressure. The residue is separated and purified by silica gel column chromatography (solvent: ammonia water saturated ether) to obtain 400.6 mg of 3-O-acetyl mesaconitine (yield 9
Five%). 100 mg of 3-O-acetyl mesaconitine is heated under reflux for 4 hours in 10 ml of a dioxane-water (1: 1) mixture. After completion of the reaction, the solvent is distilled off under reduced pressure. The obtained residue is separated and purified by column chromatography or thin layer chromatography (solvent: ammonia water saturated ether) to obtain 3-O-acetyl-14-benzoylmesaconine 77.8 mg (yield 83%).
[実施例11] ジェサコニチン100mgをメタノール30mlに溶解し、油
浴温度60〜70℃で72時間攪拌する。反応終了後、反応液
を減圧下濃縮し、残留物はシリカゲルカラムクロマトグ
ラフィー(溶媒:アンモニア水飽和エーテル)で分離、
精製し8−O−メチル−14−アニソイルアコニン84.5mg
(収率81%)を得る。[Example 11] 100 mg of gesaconitine is dissolved in 30 ml of methanol, and the mixture is stirred at an oil bath temperature of 60 to 70 ° C for 72 hours. After the reaction was completed, the reaction solution was concentrated under reduced pressure, and the residue was separated by silica gel column chromatography (solvent: ammonia water saturated ether),
Purified 8-O-methyl-14-anisoylaconine 84.5 mg
(Yield 81%) is obtained.
[実施例12] ジェサコニチン100mgをエタノール30mlに溶解し、油
浴温度60〜70℃で120時間攪拌する。反応終了後、反応
液を減圧下濃縮し、残留物はシリカゲルカラムクロマト
グラフィー(溶媒:アンモニア水飽和エーテル)で分
離、精製し8−O−エチル−14−アニソイルアコニン7
3.5mg(収率72%)を得る。[Example 12] 100 mg of gesaconitine is dissolved in 30 ml of ethanol, and the mixture is stirred at an oil bath temperature of 60 to 70 ° C for 120 hours. After completion of the reaction, the reaction solution was concentrated under reduced pressure, and the residue was separated and purified by silica gel column chromatography (solvent: ammonia water saturated ether) to give 8-O-ethyl-14-anisoylaconine 7
3.5 mg (72% yield) are obtained.
[実施例13] ジェサコニチン404mgにピリジン8mlと無水酢酸30mlを
加え室温で16時間攪拌する。反応液を減圧下濃縮乾固
し、残留物をクロロホルム50mlに溶かし、クロロホルム
層は5%NaHCO3水溶液ついで水で洗浄後、芒硝で乾燥
し、減圧下留去する。残留物はシリカゲルカラムクロマ
トグラフィー(溶媒:アンモニア水飽和エーテル)で分
離、精製し、3-O-アセチルジェサコニチン411.7mgを得
る(収率95.8%)。Example 13 To 404 mg of jesaconitine, 8 ml of pyridine and 30 ml of acetic anhydride were added, and the mixture was stirred at room temperature for 16 hours. The reaction solution is concentrated to dryness under reduced pressure, the residue is dissolved in 50 ml of chloroform, the chloroform layer is washed with a 5% NaHCO 3 aqueous solution and then with water, dried over sodium sulfate and evaporated under reduced pressure. The residue is separated and purified by silica gel column chromatography (solvent: saturated aqueous ammonia) to obtain 411.7 mg of 3-O-acetylgesaconitine (yield 95.8%).
3−O−アセチルジェサコニチン103.1mgをメタノー
ル10mlに溶解し、油浴温度60〜70℃で44時間攪拌する。
反応終了後、反応液を減圧下濃縮し、残留物はシリカゲ
ルカラムクロマトグラフィー(溶媒:アンモニア水飽和
エーテル)で分離、精製し3−O−アセチル−8−O−
メチル−14−アニソイルアコニン72.3mg(収率73%)を
得る。103.1 mg of 3-O-acetylgesaconitine is dissolved in 10 ml of methanol, and the mixture is stirred at an oil bath temperature of 60 to 70 ° C. for 44 hours.
After completion of the reaction, the reaction solution was concentrated under reduced pressure, and the residue was separated and purified by silica gel column chromatography (solvent: ammonia water saturated ether) and purified to 3-O-acetyl-8-O-.
72.3 mg (73% yield) of methyl-14-anisoylaconine are obtained.
[実施例14] ジェサコニチン404mgにピリジン8mlと無水酢酸30mlを
加え室温で16時間攪拌する。反応液を減圧下濃縮乾固
し、残留物をクロロホルム50mlに溶かし、クロロホルム
層は5%NaHCO3水溶液ついで水で洗浄後、芒硝で乾燥
し、減圧下留去する。残留物はシリカゲルカラムクロマ
トグラフィー(溶媒:アンモニア水飽和エーテル)で分
離、精製し、3-O-アセチルジェサコニチン411.7mgを得
る(収率95.8%)。3-O-アセチルジェサコニチン114.9m
gをエタノール10mlに溶解し、油浴温度60〜70℃で114時
間攪拌する。反応終了後、反応液を減圧下濃縮し、残留
物はシリカゲルカラムクロマトグラフィー(溶媒:アン
モニア水飽和エーテル)で分離、精製し3−O−アセチ
ル−8−O−エチル−14−アニソイルアコニン80.5mg
(収率72%)を得る。[Example 14] To 404 mg of jesaconitine, 8 ml of pyridine and 30 ml of acetic anhydride were added, and the mixture was stirred at room temperature for 16 hours. The reaction solution is concentrated to dryness under reduced pressure, the residue is dissolved in 50 ml of chloroform, the chloroform layer is washed with a 5% NaHCO 3 aqueous solution and then with water, dried over sodium sulfate and evaporated under reduced pressure. The residue is separated and purified by silica gel column chromatography (solvent: saturated aqueous ammonia) to obtain 411.7 mg of 3-O-acetylgesaconitine (yield 95.8%). 3-O-acetyl gesaconitine 114.9m
g is dissolved in 10 ml of ethanol and stirred at an oil bath temperature of 60 to 70 ° C for 114 hours. After completion of the reaction, the reaction solution was concentrated under reduced pressure, and the residue was separated and purified by silica gel column chromatography (solvent: ammonia water saturated ether) and purified to give 3-O-acetyl-8-O-ethyl-14-anisoylaconine. 80.5 mg
(Yield 72%) is obtained.
[実施例15] ジェサコニチン404mgにピリジン8mlと無水酢酸30mlを
加え室温で16時間攪拌する。反応液を減圧下濃縮乾固
し、残留物をクロロホルム50mlに溶かし、クロロホルム
層は5%NaHCO3水溶液ついで水で洗浄後、芒硝で乾燥
し、減圧下留去する。残留物はシリカゲルカラムクロマ
トグラフィー(溶媒:アンモニア水飽和エーテル)で分
離、精製し、3-O-アセチルジェサコニチン411.7mgを得
る(収率95.8%)。3-O-アセチルジェサコニチン100mg
をジオキサン−水(1:1)混液10ml中で4時間加熱還流
する。反応終了後、溶媒を減圧下留去する。得られた残
留物をカラムクロマトあるいは薄層クロマトグラフィー
(溶媒:アンモニア水飽和エーテル)で分離、精製し3
−O−アセチル−14−アニソイルアコニン79.9mg(収率
85%)を得る。Example 15 To 404 mg of jesaconitine, 8 ml of pyridine and 30 ml of acetic anhydride were added, and the mixture was stirred at room temperature for 16 hours. The reaction solution is concentrated to dryness under reduced pressure, the residue is dissolved in 50 ml of chloroform, the chloroform layer is washed with a 5% NaHCO 3 aqueous solution and then with water, dried over sodium sulfate and evaporated under reduced pressure. The residue is separated and purified by silica gel column chromatography (solvent: saturated aqueous ammonia) to obtain 411.7 mg of 3-O-acetylgesaconitine (yield 95.8%). 3-O-acetyl gesaconitine 100mg
Is heated to reflux in 10 ml of a dioxane-water (1: 1) mixture for 4 hours. After completion of the reaction, the solvent is distilled off under reduced pressure. The obtained residue is separated and purified by column chromatography or thin layer chromatography (solvent: ammonia water saturated ether).
-O-acetyl-14-anisoylachonin 79.9 mg (yield
85%).
[実施例16] ヒパコニチン55mgをメタノール5mlに溶解し、油浴温
度60〜70℃で72時間攪拌する。反応終了後、反応液を減
圧下濃縮し、残留物はシリカゲルカラムクロマトグラフ
ィー(溶媒:アンモニア水飽和エーテル:ヘキサン=4:
1)で分離、精製し8−O−メチル−14−ベンゾイルヒ
パコニン35.8mg(収率75%)を得る。[Example 16] 55 mg of hypaconitine is dissolved in 5 ml of methanol, and the mixture is stirred at an oil bath temperature of 60 to 70 ° C for 72 hours. After the reaction was completed, the reaction solution was concentrated under reduced pressure, and the residue was subjected to silica gel column chromatography (solvent: saturated aqueous ammonia: ether: hexane = 4:
Separation and purification in 1) yielded 35.8 mg (yield 75%) of 8-O-methyl-14-benzoylhypaconine.
[実施例17] ヒパコニチン55mgをエタノール10mlに溶解し、油浴温
度70〜80℃で72時間攪拌する。反応終了後、反応液を減
圧下濃縮し、残留物はシリカゲルカラムクロマトグラフ
ィー(溶媒:アンモニア水飽和エーテル:ヘキサン=4:
1)で分離、精製し8−O−エチル−14−ベンゾイルヒ
パコニン35.2mg(収率68%)を得る。[Example 17] Hypaconitine (55 mg) is dissolved in ethanol (10 ml), and the mixture is stirred at an oil bath temperature of 70 to 80 ° C for 72 hours. After the reaction was completed, the reaction solution was concentrated under reduced pressure, and the residue was subjected to silica gel column chromatography (solvent: saturated aqueous ammonia: ether: hexane = 4:
Separation and purification in 1) yielded 35.2 mg (68% yield) of 8-O-ethyl-14-benzoylhypaconine.
[実施例18] アコニチン100mgをアミルアルコール30mlに溶解し、
油浴温度60〜70℃で240時間攪拌する。反応終了後、反
応液を減圧下濃縮し、残留物はシリカゲルカラムクロマ
トグラフィー(溶媒:アンモニア水飽和エーテル)で分
離、精製し8−O−エチル−14−ベンゾイルアコニン7
4.3mg(収率71%)を得る。Example 18 100 mg of aconitine was dissolved in 30 ml of amyl alcohol,
Stir at an oil bath temperature of 60-70 ° C for 240 hours. After completion of the reaction, the reaction solution was concentrated under reduced pressure, and the residue was separated and purified by silica gel column chromatography (solvent: ammonia water saturated ether) to give 8-O-ethyl-14-benzoylaconine 7
4.3 mg (71% yield) are obtained.
[実施例19] アコニチン331mgにピリジン8mlと無水酢酸30mlを加え
室温で16時間攪拌する。反応液を減圧下濃縮乾固し、残
留物をクロロホルム50mlに溶かし、クロロホルム層は5
%NaHCO3水溶液ついで水で洗浄後、芒硝で乾燥し、減圧
下留去する。残留物はシリカゲルカラムクロマトグラフ
ィー(溶媒:アンモニア水飽和エーテル)で分離、精製
し、3−O−アセチルアコニチン300.9mgを得る(収率8
5.3%)。3−O−アセチルアコニチン100mgをアミルア
ルコール10mlに溶解し、油浴温度70−80℃で240時間攪
拌する。反応終了後、反応液を減圧下濃縮し、残留物は
シリカゲルカラムクロマトグラフィー(溶媒:アンモニ
ア水飽和エーテル)で分離、精製し3−O−アセチル−
8−O−アミル−14−ベンゾイルアコニン78.3mg(収率
74%)を得る。Example 19 To 331 mg of aconitine, 8 ml of pyridine and 30 ml of acetic anhydride are added, and the mixture is stirred at room temperature for 16 hours. The reaction mixture was concentrated to dryness under reduced pressure, the residue was dissolved in 50 ml of chloroform, and the chloroform layer was mixed with 5 ml.
% NaHCO 3 aqueous solution and then washed with water, dried over sodium sulfate, and evaporated under reduced pressure. The residue is separated and purified by silica gel column chromatography (solvent: ammonia water saturated ether) to obtain 300.9 mg of 3-O-acetylaconitine (yield 8
5.3%). 100 mg of 3-O-acetylaconitine is dissolved in 10 ml of amyl alcohol and stirred at an oil bath temperature of 70-80 ° C for 240 hours. After completion of the reaction, the reaction solution was concentrated under reduced pressure, and the residue was separated and purified by silica gel column chromatography (solvent: ammonia water saturated ether) and purified with 3-O-acetyl-.
8-O-amyl-14-benzoyl aconine 78.3 mg (yield
74%).
[実施例20] 実施例18において用いたアコニチン(100mg)の代わ
りにメサコニチン(100mg)を用いて、他は実施例18と
全く同様に行ない8−O−アミル−14−ベンゾイルメサ
コニン76.2mg(収率73%)を得る。Example 20 Mesaconitine (100 mg) was used in place of the aconitine (100 mg) used in Example 18, and the same operation as in Example 18 was carried out otherwise except that 76.2 mg of 8-O-amyl-14-benzoylmethaconine ( Yield 73%).
[実施例21] 実施例19において用いたアコニチン(331mg)の代わ
りにメサコニチン(408mg)を用いて、他は実施例19と
全く同様に行ない3−O−アセチル−8−O−アミル−
14−ベンゾイルメサコニン75.0mg(収率72%)を得る。Example 21 Mesaconitine (408 mg) was used in place of aconitine (331 mg) used in Example 19, and the same procedure as in Example 19 was repeated except that 3-O-acetyl-8-O-amyl-
75.0 mg (yield 72%) of 14-benzoyl mesaconine is obtained.
[実施例22] 実施例18において用いたアコニチン(100mg)の代わ
りにジェサコニチン(100mg)を用いて、他は実施例18
と全く同様に行ない8−O−アミル−14−アニソイルア
コニン78.3mg(収率75%)を得る。[Example 22] Jesaconitine (100 mg) was used in place of the aconitine (100 mg) used in Example 18, and the other examples were used.
The same procedure as described in (8) -O-amyl-14-anisoylaconine (78.3 mg, yield 75%) was obtained.
[実施例23] 実施例19において用いたアコニチン(331mg)の代わ
りにジェサコニチン(404mg)を用いて、他は実施例19
と全く同様に行ない3−O−アセチル−8−O−アミル
−14−アニソイルアコニン74.0mg(収率71%)を得る。[Example 23] In place of aconitine (331 mg) used in Example 19, gesaconitine (404 mg) was used.
The same procedure as described above was performed to obtain 74.0 mg (yield 71%) of 3-O-acetyl-8-O-amyl-14-anisoylaconine.
[実施例24] 実施例18において用いたアコニチン(100mg)の代わ
りにヒパコニチン(100mg)を用いて、他は実施例18と
全く同様に行ない8−O−アミル−14−ベンゾイルヒパ
コニン73.2mg(収率70%)を得る。[Example 24] The same procedure as in Example 18 was carried out except that hypaconitine (100 mg) was used instead of aconitine (100 mg) used in Example 18, and 8-O-amyl-14-benzoylhypaconine 73.2 mg was used. (Yield 70%) is obtained.
[実施例25] 生附子5gにメタノール100mlを加え、約100時間加熱還
流する。ついで、この抽出液をろ過し、ろ液は減圧下留
去する。得られた残留物は5%塩酸水溶液50mlに溶解
し,ヘキサン80mlで分配する。次いでこの5%塩酸水溶
液にpH約9となるまで10%アンモニア水を加え、この水
層をクロロホルム100mlで3回抽出する。[Example 25] 100 ml of methanol is added to 5 g of raw adzuki bean and heated under reflux for about 100 hours. Then, this extract is filtered, and the filtrate is distilled off under reduced pressure. The residue obtained is dissolved in 50 ml of 5% aqueous hydrochloric acid and distributed with 80 ml of hexane. Then, 10% aqueous ammonia is added to this 5% aqueous hydrochloric acid solution until the pH reaches about 9, and the aqueous layer is extracted three times with 100 ml of chloroform.
クロロホルム層は芒硝で乾燥後、減圧下留去し、約80
mgの残留物を得る。この残留物を、アセトニトリル10ml
に溶解し試料溶液とする。この試料溶液10μlにつき下
記の条件の高速液体クロマトグラフ法(HPLC)で、8−
O−メチル−14−ベンゾイルアコニン、8−O−メチル
−14−ベンゾイルメサコニン、8−O−メチル−14−ア
ニソイルアコニン、および8−O−メチル−14−ベンゾ
イルヒパコニンを分析および分取することができる。The chloroform layer was dried over Glauber's salt and evaporated under reduced pressure to give about 80
mg residue is obtained. 10 ml of this residue was added to acetonitrile.
To prepare a sample solution. For 10 μl of this sample solution, by high performance liquid chromatography (HPLC) under the following conditions,
Analyzes O-methyl-14-benzoylaconine, 8-O-methyl-14-benzoylmethaconine, 8-O-methyl-14-anisoylaconine, and 8-O-methyl-14-benzoylhypaconine And can be sorted.
(HPLC分析条件) 移動相:0.05Mりん酸緩衝液(pH2.5):テトラヒドロ
フラン:アセトニトリル=80:14:6 流速:1.0ml/min 検出波長:247nm カラム:Chemcosorb ODS-H(4.6φ×150mm) (HPLC分取条件) 移動相:メタノール:水:クロロホルム:トリエチル
アミン=80:20:2:0.1 流速:10ml/min 検出波長:247nm カラム:イナートシルODS(22.5φ×250mm) [実施例26] 実施例25において用いたメタノール(100ml)の代わ
りにエタノール(100ml)を用いて他は実施例25と全く
同様に行ない8−O−エチル−14−ベンゾイルアコニ
ン、8−O−エチル−14−ベンゾイルメサコニン、8−
O−エチル−14−アニソイルアコニンおよび8−O−エ
チル−14−ベンゾイルヒパコニンを分析および分取する
ことができる。(HPLC analysis conditions) Mobile phase: 0.05 M phosphate buffer (pH 2.5): Tetrahydrofuran: Acetonitrile = 80: 14: 6 Flow rate: 1.0 ml / min Detection wavelength: 247 nm Column: Chemcosorb ODS-H (4.6φ x 150 mm (HPLC preparative conditions) Mobile phase: Methanol: Water: Chloroform: Triethylamine = 80: 20: 2: 0.1 Flow rate: 10 ml / min Detection wavelength: 247 nm Column: Inertocyl ODS (22.5φ x 250 mm) [Example 26] Implementation Example 8 was repeated except that ethanol (100 ml) was used in place of methanol (100 ml) used in Example 25, and 8-O-ethyl-14-benzoylaconine and 8-O-ethyl-14-benzoyl were used. Mesaconine, 8-
O-ethyl-14-anisoylaconine and 8-O-ethyl-14-benzoylhypaconine can be analyzed and fractionated.
(1)8−O−メチル−14−ベンゾイルアコニンの物性
値および分析データ 1)性状および溶解性 無色の非結晶性粉末でエーテル、クロロホルム、ベン
ゼン、エタノール、メタノール、アセトン、酢酸エチ
ル、ピリジン、ジメチルスルホキシドに可溶で、ヘキサ
ン、水に不溶である。(1) Physical properties and analytical data of 8-O-methyl-14-benzoylaconine 1) Properties and solubility Colorless amorphous powder of ether, chloroform, benzene, ethanol, methanol, acetone, ethyl acetate, pyridine, Soluble in dimethyl sulfoxide, insoluble in hexane and water.
2)赤外線吸収スペクトル(KBr)分析 3420,1710cm-1に吸収の極大を示す。2) Infrared absorption spectrum (KBr) analysis The maximum absorption is shown at 3420,1710 cm -1 .
3)紫外線吸収スペクトル(エタノール)分析 4)1H核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。3) Ultraviolet absorption spectrum (ethanol) analysis 4) 1 H nuclear magnetic resonance spectrum (CDCl 3 ) analysis Shows the following signals (δ, ppm).
8.06-7.43(5H,多重線)(ベンゾイル基のH) 4.86(1H,二重線,J=4.95Hz)(14位のH) 4.60(1H,二重線,J=5.60Hz)(15位のH) 4.07(1H,二重線,J=6.27Hz)(6位のH) 1.16(3H,三重線,J=6.93Hz)(N−エチル基のメチ
ル基のH) 5)13C核磁気共鳴スペクトル(CDCl3)の分析 次のシグナルを示す(δ,ppm)。8.06-7.43 (5H, multiple line) (H of benzoyl group) 4.86 (1H, double line, J = 4.95Hz) (14th H) 4.60 (1H, double line, J = 5.60Hz) (15th place) H) 4.07 (1H, double line, J = 6.27Hz) (6th H) 1.16 (3 H, triplet, J = 6.93 Hz) (H of methyl group of N-ethyl group) 5) 13 C Nuclear magnetic resonance spectrum (CDCl 3 ) analysis The following signals are shown (δ, ppm).
166.2(14位のベンゾイル基由来のカルボニル基の
C) 132.8,130.0,129.6,128.3(ベンゾイル基のC) 93.2,83.0,82.4,82.1,79.2,77.2,74.6,71.3(16,6,1,
8,14,15,18,13,3位のC) 62.3,59.0,58.5,55.7(16,18,6,1に結合したメトキシ
基のC) 49.9(8位に結合したメトキシ基のC) 49.0(N−エチル基のメチレン基のC) 13.0(N−エチル基のメチル基のC) 6)EI−質量スペクトル分析 m/z 617(M+) (2)8−O−エチル−14−ベンゾイルアコニンの物性
値および分析データ 1)性状および溶解性 無色の非結晶性粉末でエーテル、クロロホルム、ベン
ゼン、エタノール、メタノール、アセトン、酢酸エチ
ル、ピリジン、ジメチルスルホキシドに可溶で、ヘキサ
ン、水に不溶である。166.2 (C of carbonyl group derived from benzoyl group at 14-position) 132.8,130.0,129.6,128.3 (C of benzoyl group) 93.2,83.0,82.4,82.1,79.2,77.2,74.6,71.3 (16,6,1,
8,14,15,18,13,3 position C) 62.3,59.0,58.5,55.7 (C of methoxy group bonded to 16,18,6,1) 49.9 (C of methoxy group bonded to 8 position) 49.0 (C of methylene group of N-ethyl group) 13.0 (C of methyl group of N-ethyl group) 6) EI-mass spectrum analysis m / z 617 (M + ) (2) 8-O-ethyl-14- Physical Properties and Analytical Data of Benzoylaconine 1) Properties and Solubility A colorless amorphous powder, soluble in ether, chloroform, benzene, ethanol, methanol, acetone, ethyl acetate, pyridine, dimethyl sulfoxide, and soluble in hexane and water. It is insoluble.
2)赤外線吸収スペクトル(KBr)分析 3400,1715cm-1に吸収の極大を示す。2) Infrared absorption spectrum (KBr) analysis The maximum absorption is shown at 3400,1715 cm -1 .
3)紫外線吸収スペクトル(エタノール)分析 4)1H核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。3) Ultraviolet absorption spectrum (ethanol) analysis 4) 1 H nuclear magnetic resonance spectrum (CDCl 3 ) analysis Shows the following signals (δ, ppm).
8.06-7.41(5H,多重線)(ベンゾイル基のH) 4.83(1H,二重線,J=4.95Hz)(14位のH) 4.56(1H,二重線,J=5.93Hz)(15位のH) 4.09(1H,二重線,J=6.59Hz)(6位のH) 1.13(3H,三重線,J=7.26Hz)(N−エチル基のメチ
ル基のH) 0.59(3H,三重線,J=6.29Hz)(8位に結合したエト
キシ基のメチル基のH) 5)13C核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。8.06-7.41 (5H, multiple line) (H of benzoyl group) 4.83 (1H, double line, J = 4.95Hz) (H in 14th position) 4.56 (1H, double line, J = 5.93Hz) (15th position) H) 4.09 (1H, double wire, J = 6.59Hz) (H in 6th place) 1.13 (3H, triplet, J = 7.26Hz) (H of N-ethyl group methyl group) 0.59 (3H, triplet, J = 6.29Hz) (H of methyl group of ethoxy group bonded to 8-position) 5 ) 13 C nuclear magnetic resonance spectrum (CDCl 3 ) analysis shows the following signals (δ, ppm).
166.1(14位のベンゾイル基由来のカルボニル基の
C) 132.8,130.2,129.6,128.3(ベンゾイル基のC) 93.2,83.3,82.3,82.2,79.4,76.8,74.7,71.5(16,6,1,
8,14,15,18,13,3位のC) 62.3,59.0,58.5,55.7(16,18,6,1位に結合したメトキ
シ基のC) 57.2(8位に結合したエトキシ基のメチレン基のC) 48.9(N−エチル基のメチレン基のC) 15.3(8位に結合したエトキシ基のメチル基のC) 13.1(N−エチル基のメチル基のC) 6)EI−質量スペクトル分析 m/z 631(M+) (3)3−O−アセチル−8−O−メチル−14−ベンゾ
イルアコニンの物性値および分析データ 1)性状および溶解性 無色の非結晶性粉末でエーテル、クロロホルム、ベン
ゼン、エタノール、メタノール、アセトン、酢酸エチ
ル、ピリジン、ジメチルスルホキシドに可溶で、ヘキサ
ン、水に不溶である。166.1 (C of carbonyl group derived from benzoyl group at 14-position) 132.8,130.2,129.6,128.3 (C of benzoyl group) 93.2,83.3,82.3,82.2,79.4,76.8,74.7,71.5 (16,6,1,
8,14,15,18,13,3 position C) 62.3,59.0,58.5,55.7 (C of methoxy group bonded to 16,18,6,1 position) 57.2 (Ethoxy group methylene bonded to 8 position) Group C) 48.9 (C of methylene group of N-ethyl group) 15.3 (C of methyl group of ethoxy group bonded to 8-position) 13.1 (C of methyl group of N-ethyl group) 6) EI-mass spectrometry m / z 631 (M + ) (3) Physical property values and analytical data of 3-O-acetyl-8-O-methyl-14-benzoylaconine 1) Properties and solubility A colorless amorphous powder, ether, chloroform , Soluble in benzene, ethanol, methanol, acetone, ethyl acetate, pyridine and dimethylsulfoxide, but insoluble in hexane and water.
2)赤外線吸収スペクトル(KBr)分析 3400,1710cm-1に吸収の極大を示す。2) Infrared absorption spectrum (KBr) analysis The maximum absorption is shown at 3400,1710 cm -1 .
3)紫外線吸収スペクトル(エタノール)分析 4)1H核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。3) Ultraviolet absorption spectrum (ethanol) analysis 4) 1 H nuclear magnetic resonance spectrum (CDCl 3 ) analysis Shows the following signals (δ, ppm).
8.06-7.42(5H,多重線)(ベンゾイル基のH) 5.00(1H,多重線)(3位のH) 4.84(1H,二重線,J=4.95Hz)(14位のH) 4.57(1H,二重線,J=5.60Hz)(15位のH) 4.07(1H,二重線,J=6.27Hz)(6位のH) 2.08(3H,一重線)(3位に結合したアセチル基のメ
チル基のH) 1.16(3H,三重線,J=6.93Hz)(N−エチル基のメチ
ル基のH) 5)13C核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。8.06-7.42 (5H, multiplet) (H of benzoyl group) 5.00 (1H, multiplet) (H of 3rd position) 4.84 (1H, doublet, J = 4.95Hz) (H of 14th position) 4.57 (1H , Double wire, J = 5.60Hz) (H in 15th place) 4.07 (1H, double wire, J = 6.27Hz) (H in 6th place) 2.08 (3H, singlet) (H of methyl group of acetyl group bonded to 3-position) 1.16 (3H, triplet, J = 6.93Hz) (H of methyl group of N-ethyl group) 5) 13 C Nuclear magnetic Resonance spectrum (CDCl 3 ) analysis shows the following signals (δ, ppm).
170.0(3位に結合したアセチル基のカルボニル基の
C) 166.2(14位のベンゾイル基由来のカルボニル基の
C) 132.7,130.1,129.6,128.3(ベンゾイル基のC) 93.2,83.0,82.3,81.9,79.2,78.3,77.0,74.1,71.7(1
6,6,1,8,14,15,18,13,3位のC) 62.3,59.0,58.5,55.7(16,18,6,1位に結合したメトキ
シ基のC) 49.8(8位に結合したメトキシ基のC) 49.0(N−エチル基のメチレン基のC) 21.2(3位に結合したアセチル基のメチル基のC) 13.2(N−エチル基のメチル基のC) 6)EI−質量スペクトル分析 m/z 659(M+) (4)3−O−アセチル−8−O−エチル−14−ベンゾ
イルアコニンの物性値および分析データ 1)性状および溶解性 無色の非結晶性粉末でエーテル、クロロホルム、ベン
ゼン、エタノール、メタノール、アセトン、酢酸エチ
ル、ピリジン、ジメチルスルホキシドに可溶で、ヘキサ
ン、水に不溶である。170.0 (C of carbonyl group of acetyl group bonded to 3-position) 166.2 (C of carbonyl group derived from benzoyl group of 14-position) 132.7, 130.1, 129.6, 128.3 (C of benzoyl group) 93.2, 83.0, 82.3, 81.9, 79.2,78.3,77.0,74.1,71.7 (1
6,6,1,8,14,15,18,13,3 position C) 62.3,59.0,58.5,55.7 (C of methoxy group bonded to 16,18,6,1 position) 49.8 (8 position C) of bonded methoxy group 49.0 (C of methylene group of N-ethyl group) 21.2 (C of methyl group of acetyl group bonded to 3-position) 13.2 (C of methyl group of N-ethyl group) 6) EI- Mass spectrum analysis m / z 659 (M + ) (4) Physical properties and analytical data of 3-O-acetyl-8-O-ethyl-14-benzoylaconine 1) Properties and solubility In colorless amorphous powder It is soluble in ether, chloroform, benzene, ethanol, methanol, acetone, ethyl acetate, pyridine and dimethyl sulfoxide, but insoluble in hexane and water.
2)赤外線吸収スペクトル(KBr)分析 3500,1720cm-1に吸収の極大を示す。2) Infrared absorption spectrum (KBr) analysis The maximum absorption is shown at 3500 and 1720 cm -1 .
3)紫外線吸収スペクトル(エタノール)分析 4)1H核磁気共鳴スペクトル分析(CDCl3)分析 次のシグナルを示す(δ,ppm)。3) Ultraviolet absorption spectrum (ethanol) analysis 4) 1 H nuclear magnetic resonance spectrum analysis (CDCl 3 ) analysis The following signals are shown (δ, ppm).
8.06-7.41(5H,多重線)(ベンゾイル基のH) 4.97(1H,多重線)(3位のH) 4.82(1H,二重線,J=4.95Hz)(14位のH) 4.53(1H,二重線,J=5.94Hz)(15位のH) 4.18(1H,二重線,J=6.59Hz)(6位のH) 2.07(3H,一重線)(3位に結合したアセチル基のメ
チル基のH) 1.11(3H,三重線,J=7.09Hz)(N−エチル基のメチ
ル基のH) 0.58(3H,三重線,J=6.76Hz)(8位に結合したエト
キシ基のメチル基のH) 5)13C核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。8.06-7.41 (5H, multiplex) (benzoyl group H) 4.97 (1H, multiplex) (3rd position H) 4.82 (1H, double line, J = 4.95Hz) (14th position H) 4.53 (1H , Double wire, J = 5.94Hz) (15th place H) 4.18 (1H, double wire, J = 6.59Hz) (6th place H) 2.07 (3H, singlet) (H of the methyl group of the acetyl group bonded to the 3-position) 1.11 (3H, triplet, J = 7.09Hz) (H of the methyl group of the N-ethyl group) 0.58 (3H, triplet , J = 6.76 Hz) (H of the methyl group of the ethoxy group bonded to the 8-position) 5) 13 C Nuclear magnetic resonance spectrum (CDCl 3 ) analysis The following signals are shown (δ, ppm).
170.2(3位に結合したアセチル基のカルボニル基の
C) 166.2(14位のベンゾイル基由来のカルボニル基の
C) 132.7,130.3,129.6,128.2(ベンゾイル基のC) 93.6,83.4,82.3,82.0,79.5,78.5,77.0,74.8,71.5(1
6,6,1,8,14,15,18,13,3位のC) 62.3,60.9,58.7,56.4(16,18,6,1位に結合したメトキ
シ基のC) 57.1(8位に結合したエトキシ基のメチレン基のC) 49.1(N−エチル基のメチレン基のC) 21.2(3位に結合したアセチル基のメチル基のC) 15.3(8位に結合したエトキシ基のメチル基のC) 13.5(N−エチル基のメチル基のC) 6)EI−質量スペクトル分析 m/z 673(M+) (5)3−O−アセチル−14−ベンゾイルアコニンの物
性値および分析データ 1)性状および溶解性 無色の非結晶性粉末でエーテル、クロロホルム、ベン
ゼン、エタノール、メタノール、アセトン、酢酸エチ
ル、ピリジン、ジメチルスルホキシドに可溶で、ヘキサ
ン、水に不溶である。170.2 (C of carbonyl group of acetyl group bonded to 3-position) 166.2 (C of carbonyl group derived from benzoyl group of 14-position) 132.7, 130.3, 129.6, 128.2 (C of benzoyl group) 93.6, 83.4, 82.3, 82.0, 79.5,78.5,77.0,74.8,71.5 (1
6,6,1,8,14,15,18,13,3 position C) 62.3,60.9,58.7,56.4 (C of methoxy group bonded to 16,18,6,1 position) 57.1 (8 position C. of the methylene group of the bound ethoxy group) 49.1 (C of the methylene group of the N-ethyl group) 21.2 (C of the methyl group of the acetyl group bound to the 3-position) 15.3 (of C) 13.5 (C of methyl group of N-ethyl group) 6) EI-mass spectrum analysis m / z 673 (M + ) (5) Physical property value and analytical data of 3-O-acetyl-14-benzoylaconine 1 ) Properties and solubility It is a colorless amorphous powder which is soluble in ether, chloroform, benzene, ethanol, methanol, acetone, ethyl acetate, pyridine and dimethyl sulfoxide, but insoluble in hexane and water.
2)赤外線吸収スペクトル(KBr)分析 3500,1720cm-1に吸収の極大を示す。2) Infrared absorption spectrum (KBr) analysis The maximum absorption is shown at 3500 and 1720 cm -1 .
3)紫外線吸収スペクトル(エタノール)分析 4)1H核磁気共鳴スペクトル分析(CDCl3)分析 次のシグナルを示す(δ,ppm)。3) Ultraviolet absorption spectrum (ethanol) analysis 4) 1 H nuclear magnetic resonance spectrum analysis (CDCl 3 ) analysis The following signals are shown (δ, ppm).
8.06-7.41(5H,多重線)(ベンゾイル基のH) 4.98(1H,多重線)(3位のH) 4.80(1H,二重線,J=4.95Hz)(14位のH) 4.53(1H,二重線,J=5.94Hz)(15位のH) 4.18(1H,二重線,J=6.59Hz)(6位のH) 2.07(3H,一重線)(3位に結合したアセチル基のメ
チル基のH) 1.11(3H,三重線,J=7.09Hz)(N−エチル基のメチ
ル基のH) 5)13C核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。8.06-7.41 (5H, multiple line) (H of benzoyl group) 4.98 (1H, multiple line) (H of 3rd position) 4.80 (1H, double line, J = 4.95Hz) (H of 14th position) 4.53 (1H , Double wire, J = 5.94Hz) (15th place H) 4.18 (1H, double wire, J = 6.59Hz) (6th place H) 2.07 (3H, singlet) (H of methyl group of acetyl group bonded to 3-position) 1.11 (3H, triplet, J = 7.09Hz) (H of methyl group of N-ethyl group) 5) 13 C Nuclear magnetic Resonance spectrum (CDCl 3 ) analysis shows the following signals (δ, ppm).
170.2(3位に結合したアセチル基のカルボニル基の
C) 166.2(14位のベンゾイル基由来のカルボニル基の
C) 132.7,130.3,129.6,128.2(ベンゾイル基のC) 90.7,83.5,82.4,81.3,79.5,78.5,77.3,74.8,71.5(1
6,6,1,15,14,8,18,13,3位のC) 62.0,59.9,58.7,56.2(16,18,6,1に結合したメトキシ
基のC) 49.1(N−エチル基のメチレン基のC) 21.2(3位に結合したアセチル基のメチル基のC) 13.5(N−エチル基のメチル基のC) 6)EI−質量スペクトル分析 m/z 645(M+) (6)8−O−メチル−14−ベンゾイルメサコニンの物
性値および分析データ 1)性状および溶解性 無色の非結晶性粉末でエーテル、クロロホルム、ベン
ゼン、エタノール、メタノール、アセトン、酢酸エチ
ル、ピリジン、ジメチルスルホキシドに可溶で、ヘキサ
ン、水に不溶である。170.2 (C of carbonyl group of acetyl group bonded to 3-position) 166.2 (C of carbonyl group derived from benzoyl group of 14-position) 132.7, 130.3, 129.6, 128.2 (C of benzoyl group) 90.7, 83.5, 82.4, 81.3, 79.5,78.5,77.3,74.8,71.5 (1
6,6,1,15,14,8,18,13,3 position C) 62.0,59.9,58.7,56.2 (C of methoxy group bonded to 16,18,6,1) 49.1 (N-ethyl group Of the methylene group of 2) (C of the methyl group of the acetyl group bonded to the 3-position) 13.5 (C of the methyl group of the N-ethyl group) 6) EI-mass spectrum analysis m / z 645 (M + ) (6 ) Physical properties and analytical data of 8-O-methyl-14-benzoylmesaconine 1) Properties and solubility Colorless amorphous powder of ether, chloroform, benzene, ethanol, methanol, acetone, ethyl acetate, pyridine, dimethyl sulfoxide. Soluble in water and insoluble in hexane and water.
2)赤外線吸収スペクトル(KBr)分析 3450,1720cm-1に吸収の極大を示す。2) Infrared absorption spectrum (KBr) analysis The absorption maximum is shown at 3450 and 1720 cm -1 .
3)紫外線吸収スペクトル(エタノール)分析 4)1H核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。3) Ultraviolet absorption spectrum (ethanol) analysis 4) 1 H nuclear magnetic resonance spectrum (CDCl 3 ) analysis Shows the following signals (δ, ppm).
8.10-7.45(5H,多重線)(ベンゾイル基のH) 4.48(1H,二重線,J=4.50Hz)(14位のH) 4.06(1H,二重線,J=6.27Hz)(6位のH) 2.37(3H,一重線)(N−メチル基のH) 5)13C核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。8.10-7.45 (5H, multiple line) (H of benzoyl group) 4.48 (1H, double line, J = 4.50Hz) (H at 14th position) 4.06 (1H, double line, J = 6.27Hz) (6th position) H) 2.37 (3H, singlet) (H of N-methyl group) 5) 13 C Nuclear magnetic resonance spectrum (CDCl 3 ) analysis The following signals are shown (δ, ppm).
166.2(14位のベンゾイル基由来のカルボニル基の
C) 132.8,130.1,129.6,128.3(ベンゾイル基のC) 93.4,83.1,82.6,82.1,79.4,77.5,74.3,71.4(16,6,1,
8,14,15,18,13,3位のC) 62.3,59.1,58.5,56.3(16,18,6,1に結合したメトキシ
基のC) 49.7(8位に結合したメトキシ基のC) 42.4(N−メチル基のC) 6)EI−質量スペクトル分析 m/z 603(M+) 7)元素分析 計算値 C,53.22;H,6.70;N,1.94(C32H45NO10・HClO4
・H2O) 実測値 C,53.54;H,6.62;N,1.64 (7)8−O−エチル−14−ベンゾイルメサコニンの物
性値および分析データ 1)性状および溶解性 無色の非結晶性粉末でエーテル、クロロホルム、ベン
ゼン、エタノール、メタノール、アセトン、酢酸エチ
ル、ピリジン、ジメチルスルホキシドに可溶で、ヘキサ
ン、水に不溶である。166.2 (C of carbonyl group derived from benzoyl group at 14-position) 132.8,130.1,129.6,128.3 (C of benzoyl group) 93.4,83.1,82.6,82.1,79.4,77.5,74.3,71.4 (16,6,1,
8,14,15,18,13,3-position C) 62.3,59.1,58.5,56.3 (C of methoxy group bonded to 16,18,6,1) 49.7 (C of methoxy group bonded to 8-position) 42.4 (C of N-methyl group) 6) EI-mass spectrum analysis m / z 603 (M + ) 7) Elemental analysis calculated value C, 53.22; H, 6.70; N, 1.94 (C 32 H 45 NO 10 · HClO Four
・ H 2 O) Actual value C, 53.54; H, 6.62; N, 1.64 (7) Physical property value and analytical data of 8-O-ethyl-14-benzoylmethaconine 1) Property and solubility Colorless non-crystalline powder It is soluble in ether, chloroform, benzene, ethanol, methanol, acetone, ethyl acetate, pyridine and dimethylsulfoxide, but insoluble in hexane and water.
2)赤外線吸収スペクトル(KBr)分析 3450,1715cm-1に吸収の極大を示す。2) Infrared absorption spectrum (KBr) analysis The absorption maximum is shown at 3450,1715 cm -1 .
3)紫外線吸収スペクトル(エタノール)分析 4)1H核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。3) Ultraviolet absorption spectrum (ethanol) analysis 4) 1 H nuclear magnetic resonance spectrum (CDCl 3 ) analysis Shows the following signals (δ, ppm).
8.08-7.27(5H,多重線)(ベンゾイル基のH) 4.81(1H,二重線,J=4.70Hz)(14位のH) 4.54(1H,二重線,J=6.10Hz)(15位のH) 4.08(1H,二重線,J=7.60Hz)(6位のH) 2.34(3H,一重線)(N−メチル基のH) 0.57(3H,三重線,J=6.00Hz)(8位に結合したエト
キシ基のメチル基のH) 5)13C核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。8.08-7.27 (5H, multiple line) (H of benzoyl group) 4.81 (1H, double line, J = 4.70Hz) (H at 14th position) 4.54 (1H, double line, J = 6.10Hz) (15th position) H) 4.08 (1H, double wire, J = 7.60Hz) (6th H) 2.34 (3H, singlet) (H of N-methyl group) 0.57 (3H, triplet, J = 6.00Hz) (H of methyl group of ethoxy group bonded to 8-position) 5) 13 C Nuclear magnetic resonance spectrum ( CDCl 3 ) analysis shows the following signals (δ, ppm).
166.1(14位のベンゾイル基由来のカルボニル基の
C) 132.8,130.3,129.6,128.3(ベンゾイル基のC) 93.4,83.3,82.7,82.0,79.4,78.3,76.4,74.7,71.3(1
6,6,1,8,14,15,18,13,3位のC) 62.4,59.1,58.6,56.3(16,18,6,1に結合したメトキシ
基のC) 57.1(8位に結合したエトキシ基のメチレン基のC) 42.5(N−メチル基のC) 15.3(8位に結合したエトキシ基のメチル基のH) 6)EI−質量スペクトル分析 m/z 617(M+) 7)高分解能質量スペクトル分析 計算値:617.320(C33H47NO10) 実測値:617.321 (8)3−O−アセチル−8−O−エチル−14−ベンゾ
イルメサコニンの物性値および分析データ 1)性状および溶解性 無色の非結晶性粉末でエーテル、クロロホルム、ベン
ゼン、エタノール、メタノール、アセトン、酢酸エチ
ル、ピリジン、ジメチルスルホキシドに可溶で、ヘキサ
ン、水に不溶である。166.1 (C of carbonyl group derived from benzoyl group at 14th position) 132.8, 130.3, 129.6, 128.3 (C of benzoyl group) 93.4, 83.3, 82.7, 82.0, 79.4, 78.3, 76.4, 74.7, 71.3 (1
6,6,1,8,14,15,18,13,3 position C) 62.4,59.1,58.6,56.3 (C of methoxy group bonded to 16,18,6,1) 57.1 (bonded to 8 position Methylene group C of the ethoxy group 42.5 (C of the N-methyl group) 15.3 (H of the methyl group of the ethoxy group bonded to the 8-position) 6) EI-mass spectrum analysis m / z 617 (M + ) 7) high resolution mass spectrum calcd: 617.320 (C 33 H 47 NO 10) Found: 617.321 (8) 3-O- acetyl--8-O-ethyl-14-benzoyl Mesako Nin of physical properties and analytical data 1) properties And Solubility A colorless amorphous powder that is soluble in ether, chloroform, benzene, ethanol, methanol, acetone, ethyl acetate, pyridine and dimethyl sulfoxide, but insoluble in hexane and water.
2)赤外線吸収スペクトル(KBr)分析 3420,1710cm-1に吸収の極大を示す。2) Infrared absorption spectrum (KBr) analysis The maximum absorption is shown at 3420,1710 cm -1 .
3)紫外線吸収スペクトル(エタノール)分析 4)1H核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。3) Ultraviolet absorption spectrum (ethanol) analysis 4) 1 H nuclear magnetic resonance spectrum (CDCl 3 ) analysis Shows the following signals (δ, ppm).
8.02-7.45(5H,多重線)(ベンゾイル基のH) 4.97(1H,多重線)(3位のH) 4.85(1H,二重線,J=4.28Hz)(14位のH) 4.56(1H,二重線,J=5.90Hz)(15位のH) 4.16(1H,二重線,J=5.93Hz)(6位のH) 2.09(3H,一重線)(3位に結合したアセチル基のメ
チル基のH) 5)13C核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。8.02-7.45 (5H, multiple line) (H of benzoyl group) 4.97 (1H, multiple line) (H of 3rd position) 4.85 (1H, double line, J = 4.28Hz) (H of 14th position) 4.56 (1H , Double wire, J = 5.90Hz) (15th H) 4.16 (1H, double wire, J = 5.93Hz) (6th H) 2.09 (3H, singlet) (H of methyl group of acetyl group bonded to 3-position) 5) 13 C Nuclear magnetic resonance spectrum (CDCl 3 ) analysis The following signals are shown (δ, ppm).
170.2(3位に結合したアセチル基のカルボニル基の
C) 166.2(14位のベンゾイル基由来のカルボニル基の
C) 132.8,130.2,129.7,128.3(ベンゾイル基のC) 93.3,83.0,82.2,81.9,79.2,77.6,77.0,74.8,71.5(1
6,6,1,8,14,15,18,13,3位のC) 62.2,58.8,56.6,50.1(16,18,6,1に結合したメトキシ
基のC) 49.8(8位に結合したメトキシ基のC) 42.7(N−メチル基のC) 21.2(3位に結合したアセチル基のメチル基のH) 6)EI−質量スペクトル分析 m/z 645(M+) (9)3−O−アセチル−8−O−エチル−14−ベンゾ
イルメサコニンの物性値および分析データ 1)性状および溶解性 無色の非結晶性粉末でエーテル、クロロホルム、ベン
ゼン、エタノール、メタノール、アセトン、酢酸エチ
ル、ピリジン、ジメチルスルホキシドに可溶で、ヘキサ
ン、水に不溶である。170.2 (C of carbonyl group of acetyl group bonded to 3-position) 166.2 (C of carbonyl group derived from benzoyl group of 14-position) 132.8, 130.2, 129.7, 128.3 (C of benzoyl group) 93.3, 83.0, 82.2, 81.9, 79.2,77.6,77.0,74.8,71.5 (1
6,6,1,8,14,15,18,13,3 position C) 62.2,58.8,56.6,50.1 (C of methoxy group bonded to 16,18,6,1) 49.8 (bonded to 8 position C of methoxy group 42.7 (C of N-methyl group) 21.2 (H of methyl group of acetyl group bonded to 3-position) 6) EI-mass spectrum analysis m / z 645 (M + ) (9) 3- Physical properties and analytical data of O-acetyl-8-O-ethyl-14-benzoylmesaconine 1) Properties and solubility Colorless amorphous powder, ether, chloroform, benzene, ethanol, methanol, acetone, ethyl acetate, pyridine , Soluble in dimethylsulfoxide, insoluble in hexane and water.
2)赤外線吸収スペクトル(KBr)分析 3500,1720cm-1に吸収の極大を示す。2) Infrared absorption spectrum (KBr) analysis The maximum absorption is shown at 3500 and 1720 cm -1 .
3)紫外線吸収スペクトル(エタノール)分析 4)1H核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。3) Ultraviolet absorption spectrum (ethanol) analysis 4) 1 H nuclear magnetic resonance spectrum (CDCl 3 ) analysis Shows the following signals (δ, ppm).
8.06-7.41(5H,多重線)(ベンゾイル基のH) 4.96(1H,多重線)(3位のH) 4.82(1H,二重線,J=4.95Hz)(14位のH) 4.54(1H,二重線,J=5.94Hz)(15位のH) 4.14(1H,二重線,J=6.92Hz)(6位のH) 2.08(3H,一重線)(3位に結合したアセチル基のメ
チル基のH) 0.57(3H,三重線,J=6.92Hz)(8位に結合したエト
キシ基のメチル基のH) 5)13C核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。8.06-7.41 (5H, multiplet) (H of benzoyl group) 4.96 (1H, multiplet) (H of 3rd position) 4.82 (1H, doublet, J = 4.95Hz) (H of 14th position) 4.54 (1H , Double wire, J = 5.94Hz) (15th H) 4.14 (1H, double wire, J = 6.92Hz) (6th H) 2.08 (3H, singlet) (H of methyl group of acetyl group bonded to 3-position) 0.57 (3H, triplet, J = 6.92Hz) (H of methyl group of ethoxy group bonded to 8-position) 5) 13 C nuclear magnetic resonance spectrum (CDCl 3 ) analysis shows the following signals (δ, ppm).
170.2(3位に結合したアセチル基のカルボニル基の
C) 166.2(14位のベンゾイル基由来のカルボニル基の
C) 132.8,129.6,128.2(ベンゾイル基のC) 93.3,82.0,79.3,78.3,77.0,74.6,71.4(16,6,1,8,14,
15,18,13,3位のC) 62.1,58.8,56.6(16,18,6,1に結合したメトキシ基の
C) 57.1(8位に結合したエトキシ基のメチレン基のC) 42.6(N−メチル基のC) 21.2(3位に結合したアセチル基のメチル基のC) 15.2(8位に結合したエトキシ基のメチル基のH) 6)EI−質量スペクトル分析 m/z 659(M+) (10)3-O−アセチル−14−ベンゾイルメサコニンの物
性値および分析データ 1)性状および溶解性 無色の非結晶性粉末でエーテル、クロロホルム、ベン
ゼン、エタノール、メタノール、アセトン、酢酸エチ
ル、ピリジン、ジメチルスルホキシドに可溶で、ヘキサ
ン、水に不溶である。170.2 (C of carbonyl group of acetyl group bonded to 3-position) 166.2 (C of carbonyl group derived from benzoyl group of 14-position) 132.8,129.6,128.2 (C of benzoyl group) 93.3,82.0,79.3,78.3,77.0, 74.6,71.4 (16,6,1,8,14,
15,18,13,3-position C) 62.1,58.8,56.6 (C of methoxy group bonded to 16,18,6,1) 57.1 (C of methylene group of ethoxy group bonded to 8-position) 42.6 (N -C of methyl group 21.2 (C of methyl group of acetyl group bonded to 3-position) 15.2 (H of methyl group of ethoxy group bonded to 8-position) 6) EI-mass spectrum analysis m / z 659 (M + ) (10) Physical properties and analytical data of 3-O-acetyl-14-benzoylmesaconine 1) Properties and solubility Colorless amorphous powder of ether, chloroform, benzene, ethanol, methanol, acetone, ethyl acetate, pyridine , Soluble in dimethylsulfoxide, insoluble in hexane and water.
2)赤外線吸収スペクトル(KBr)分析 3420,1710cm-1に吸収の極大を示す。2) Infrared absorption spectrum (KBr) analysis The maximum absorption is shown at 3420,1710 cm -1 .
3)紫外線吸収スペクトル(エタノール)分析 4)1H核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。3) Ultraviolet absorption spectrum (ethanol) analysis 4) 1 H nuclear magnetic resonance spectrum (CDCl 3 ) analysis Shows the following signals (δ, ppm).
8.06-7.43(5H,多重線)(ベンゾイル基のH) 4.96(1H,多重線)(3位のH) 4.86(1H,二重線,J=4.95Hz)(14位のH) 4.60(1H,二重線,J=5.60Hz)(15位のH) 4.07(1H,二重線,J=6.27Hz)(6位のH) 2.09(3H,一重線)(3位に結合したアセチル基のメ
チル基のH) 5)13C核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。8.06-7.43 (5H, multiplet) (H of benzoyl group) 4.96 (1H, multiplet) (H of 3rd position) 4.86 (1H, doublet, J = 4.95Hz) (H of 14th position) 4.60 (1H , Double wire, J = 5.60Hz) (H in 15th place) 4.07 (1H, double wire, J = 6.27Hz) (H in 6th place) 2.09 (3H, singlet) (H of methyl group of acetyl group bonded to 3-position) 5) 13 C Nuclear magnetic resonance spectrum (CDCl 3 ) analysis The following signals are shown (δ, ppm).
170.2(3位に結合したアセチル基のカルボニル基
C) 166.2(14位のベンゾイル基由来のカルボニル基の
C) 132.8,130.0,129.6,128.3(ベンゾイル基のC) 91.0,83.0,82.4,82.5,79.3,77.2,74.6,71.3(16,6,1,
15,14,8,18,13,3位のC) 62.3,59.0,58.5,55.7(16,18,6,1に結合したメトキシ
基のC) 42.7(N−メチル基のC) 21.3(3位に結合したアセチル基のメチル基のH) 6)EI−質量スペクトル分析 m/z 631(M+) (11)8-O−メチル−14−アニソイルアコニンの物性値
および分析データ 1)性状および溶解性 無色の非結晶性粉末でエーテル、クロロホルム、ベン
ゼン、エタノール、メタノール、アセトン、酢酸エチ
ル、ピリジン、ジメチルスルホキシドに可溶で、ヘキサ
ン、水に不溶である。170.2 (carbonyl group C of acetyl group bonded to 3-position) 166.2 (C of carbonyl group derived from benzoyl group of 14-position) 132.8,130.0,129.6,128.3 (C of benzoyl group) 91.0,83.0,82.4,82.5,79.3 , 77.2,74.6,71.3 (16,6,1,
15,14,8,18,13,3 position C) 62.3,59.0,58.5,55.7 (C of methoxy group bonded to 16,18,6,1) 42.7 (C of N-methyl group) 21.3 (3 H) of the methyl group of the acetyl group bonded to position 6) EI-mass spectrometric analysis m / z 631 (M + ) (11) Physical properties and analytical data of 8-O-methyl-14-anisoylaconine 1) Properties and solubility A colorless, amorphous powder that is soluble in ether, chloroform, benzene, ethanol, methanol, acetone, ethyl acetate, pyridine, and dimethyl sulfoxide, but insoluble in hexane and water.
2)[α]▲24 D▼=+7.5°(c=0.93,エタノール) 3)赤外線吸収スペクトル(KBr)分析 3450,1720cm-1に吸収の極大を示す。2) [α] ▲ 24 D ▼ = + 7.5 ° (c = 0.93, ethanol) 3) Infrared absorption spectrum (KBr) analysis 3450,1720 cm -1 shows the maximum absorption.
4)紫外線吸収スペクトル(エタノール)分析 5)1H核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。4) Ultraviolet absorption spectrum (ethanol) analysis 5) 1 H nuclear magnetic resonance spectrum (CDCl 3 ) analysis The following signals are shown (δ, ppm).
4.55(1H,二重線,J=6.00Hz)(14位のH) 3.87(3H,一重線)(アニソイル基のメトキシ基の
H) 1.13(3H,三重線,J=7.26Hz)(N−エチル基のメチ
ル基のH) 6)13C核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。 4.55 (1H, double line, J = 6.00Hz) (H at 14th position) 3.87 (3H, single line) (H at methoxy group of anisoyl group) 1.13 (3 H, triplet, J = 7.26 Hz) (H of methyl group of N-ethyl group) 6) 13 C Nuclear magnetic resonance spectrum (CDCl 3 ) analysis The following signals are shown (δ, ppm).
165.7(14位のアニソイル基由来のカルボニル基の
C) 163.2,131.6,122.4,113.5(アニソイル基のC) 93.3,83.1,82.2,82.2,79.4,76.9,74.7,71.5(16,6,1,
8,14,15,18,13,3位のC) 62.3,59.0,58.4,55.6(16,18,6,1に結合したメトキシ
基のC) 55.3(アニソイル基のメトキシ基のC) 49.8(8位に結合したメトキシ基のC) 48.8(N−エチル基のメチレン基のC) 13.0(N−エチル基のメチル基のC) 7)EI−質量スペクトル分析 m/z 647(M+) 8)高分解能質量スペクトル分析 計算値:647.330(C34H49NO11) 実測値:647.328 (12)8-O−エチル−14−アニソイルアコニンの物性値
および分析データ 1)性状および溶解性 無色の非結晶性粉末でエーテル、クロロホルム、ベン
ゼン、エタノール、メタノール、アセトン、酢酸エチ
ル、ピリジン、ジメチルスルホキシドに可溶で、ヘキサ
ン、水に不溶である。165.7 (C of carbonyl group derived from 14th anisoyl group) 163.2,131.6,122.4,113.5 (C of anisoyl group) 93.3,83.1,82.2,82.2,79.4,76.9,74.7,71.5 (16,6,1,
8,14,15,18,13,3 position C) 62.3,59.0,58.4,55.6 (C of methoxy group bonded to 16,18,6,1) 55.3 (C of methoxy group of anisoyl group) 49.8 ( C of methoxy group bonded to 8-position 48.8 (C of methylene group of N-ethyl group) 13.0 (C of methyl group of N-ethyl group) 7) EI-mass spectrum analysis m / z 647 (M + ) 8 ) High resolution mass spectrum analysis Calculated value: 647.330 (C 34 H 49 NO 11 ) Actual value: 647.328 (12) Physical properties and analytical data of 8-O-ethyl-14-anisoylaconine 1) Property and solubility Colorless It is a non-crystalline powder, soluble in ether, chloroform, benzene, ethanol, methanol, acetone, ethyl acetate, pyridine and dimethyl sulfoxide, but insoluble in hexane and water.
2)[α]▲24 D▼=+5.8°(c=1.80,エタノール) 3)赤外線吸収スペクトル(KBr)分析 3450,1720cm-1に吸収の極大を示す。2) [α] 24 D ▼ = + 5.8 ° (c = 1.80, ethanol) 3) Infrared absorption spectrum (KBr) analysis 3450,1720 cm −1 shows the maximum absorption.
4)紫外線吸収スペクトル(エタノール)分析 5)1H核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。4) Ultraviolet absorption spectrum (ethanol) analysis 5) 1 H nuclear magnetic resonance spectrum (CDCl 3 ) analysis The following signals are shown (δ, ppm).
4.60(1H,二重線,J=6.00Hz)(14位のH) 3.88(3H,一重線)(アニソイル基のメトキシ基の
H) 1.11(3H,三重線,J=7.00Hz)(N−エチル基のメチ
ル基のH) 0.64(3H,三重線,J=6.00Hz)(8位に結合したエト
キシ基のメチル基のH) 6)13C核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。 4.60 (1H, doublet, J = 6.00Hz) (H at 14th position) 3.88 (3H, singlet) (H of methoxy group of anisoyl group) 1.11 (3H, triplet, J = 7.00Hz) (H of methyl group of N-ethyl group) 0.64 (3H, triplet, J = 6.00Hz) (H of methyl group of ethoxy group bonded to 8-position) 6 ) 13 C nuclear magnetic resonance spectrum (CDCl 3 ) analysis shows the following signals (δ, ppm).
165.8(14位のアニソイル基由来のカルボニル基の
C) 163.1,131.6,122.7,113.6(アニソイル基のC) 93.3,83.4,82.5,82.1,79.2,77.3,74.2,71.6(16,6,1,
8,14,15,18,13,3位のC) 62.3,59.0,58.5,55.8(16,18,6,1に結合したメトキシ
基のC) 55.3(アニソイル基のメトキシ基のC) 57.1(8位に結合したエトキシ基のメチレン基のC) 48.8(N−エチル基のメチレン基のC) 15.3(8位に結合したエトキシ基のメチル基のC) 13.0(N−エチル基のメチル基のC) 7)EI−質量スペクトル分析 m/z 661(M+) 8)高分解能質量スペクトル分析 計算値:661.349(C35H51NO11) 実測値:661.346 (13)3−O−アセチル−8-O−メチル−14−アニソイ
ルアコニンの物性値および分析データ 1)性状および溶解性 無色の非結晶性粉末でエーテル、クロロホルム、ベン
ゼン、エタノール、メタノール、アセトン、酢酸エチ
ル、ピリジン、ジメチルスルホキシドに可溶で、ヘキサ
ン、水に不溶である。165.8 (C of carbonyl group derived from 14th anisoyl group) 163.1,131.6,122.7,113.6 (C of anisoyl group) 93.3,83.4,82.5,82.1,79.2,77.3,74.2,71.6 (16,6,1,
8,14,15,18,13,3 position C) 62.3,59.0,58.5,55.8 (C of the methoxy group bonded to 16,18,6,1) 55.3 (C of the methoxy group of anisoyl group) 57.1 ( Methylene group of the ethoxy group bonded to the 8-position C) 48.8 (C of the methylene group of the N-ethyl group) 15.3 (Methyl group of the ethoxy group bonded to the 8-position) 13.0 (Methyl group of the N-ethyl group) C) 7) EI- mass spectrometry m / z 661 (M +) 8) high resolution mass spectrum calcd: 661.349 (C 35 H 51 NO 11) Found: 661.346 (13) 3-O- acetyl -8 Physical properties and analytical data of -O-methyl-14-anisoylaconine 1) Properties and solubility Colorless amorphous powder in ether, chloroform, benzene, ethanol, methanol, acetone, ethyl acetate, pyridine, dimethyl sulfoxide. Soluble and insoluble in hexane and water.
2)赤外線吸収スペクトル(KBr)分析 3500,1710cm-1に吸収の極大を示す。2) Infrared absorption spectrum (KBr) analysis The maximum absorption is shown at 3500,1710 cm -1 .
3)紫外線吸収スペクトル(エタノール)分析 4)1H核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。3) Ultraviolet absorption spectrum (ethanol) analysis 4) 1 H nuclear magnetic resonance spectrum (CDCl 3 ) analysis Shows the following signals (δ, ppm).
4.95(1H,多重線)(3位のH) 4.81(1H,二重線,J=4.95Hz)(14位のH) 4.53(1H,二重線,J=5.94Hz)(15位のH) 4.11(1H,二重線,J=6.60Hz)(6位のH) 3.86(3H,一重線)(アニソイル基のメトキシ基の
H) 2.07(3H,一重線)(3位に結合したアセチル基のメ
チル基のH) 1.11(3H,三重線,J=7.26Hz)(N−エチル基のメチ
ル基のH) 5)13C核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。 4.95 (1H, multiple line) (3rd H) 4.81 (1H, double line, J = 4.95Hz) (14th H) 4.53 (1H, double line, J = 5.94Hz) (15th H) ) 4.11 (1H, doublet, J = 6.60Hz) (H at 6th position) 3.86 (3H, singlet) (H of methoxy group of anisoyl group) 2.07 (3H, singlet) (H of methyl group of acetyl group bonded to 3-position) 1.11 (3H, triplet, J = 7.26Hz) (H of methyl group of N-ethyl group) 5) 13 C Nuclear magnetic Resonance spectrum (CDCl 3 ) analysis shows the following signals (δ, ppm).
170.3(3位に結合したアセチル基のカルボニル基の
C) 166.0(14位のアニソイル基由来のカルボニル基の
C) 163.2,131.8,122.8,113.6(アニソイル基のC) 93.6,83.3,82.2,79.2,77.8,77.0,74.9,71.3(16,6,1,
8,14,15,18,13,3位のC) 62.4,58.8,55.4(16,18,6,1に結合したメトキシ基の
C) 55.4(アニソイル基のメトキシ基のC) 49.8(8位に結合したメトキシ基のC) 49.2(N−エチル基のメチレン基のC) 21.3(3位に結合したアセチル基のメチル基のC) 13.5(N−エチル基のメチル基のC) 6)EI−質量スペクトル分析 m/z 689(M+) 7)高分解能質量スペクトル分析 計算値:689.340(C36H51NO12) 実測値:689.339 (14)3−O−アセチル−8−O−エチル−14−アニソ
イルアコニンの物性値および分析データ 1)性状および溶解性 無色の非結晶性粉末でエーテル、クロロホルム、ベン
ゼン、エタノール、メタノール、アセトン、酢酸エチ
ル、ピリジン、ジメチルスルホキシドに可溶で、ヘキサ
ン、水に不溶である。170.3 (C of carbonyl group of acetyl group bonded to 3-position) 166.0 (C of carbonyl group derived from anisoyl group of 14-position) 163.2,131.8,122.8,113.6 (C of anisoyl group) 93.6,83.3,82.2,79.2, 77.8,77.0,74.9,71.3 (16,6,1,
8,14,15,18,13,3 position C) 62.4,58.8,55.4 (C of methoxy group bonded to 16,18,6,1) 55.4 (C of anisoyl group methoxy group) 49.8 (8 position C of methoxy group bound to 4) (C of methylene group of N-ethyl group) 21.3 (C of methyl group of acetyl group bound to 3-position) 13.5 (C of methyl group of N-ethyl group) 6) EI - mass spectrometry m / z 689 (M +) 7) high resolution mass spectrum calcd: 689.340 (C 36 H 51 NO 12) Found: 689.339 (14) 3-O- acetyl--8-O-ethyl - Physical properties and analytical data of 14-anisoylaconine 1) Properties and solubility A colorless amorphous powder soluble in ether, chloroform, benzene, ethanol, methanol, acetone, ethyl acetate, pyridine, dimethyl sulfoxide, and hexane. , Insoluble in water.
2)赤外線吸収スペクトル(KBr)分析 3450,1705cm-1に吸収の極大を示す。2) Infrared absorption spectrum (KBr) analysis The absorption maximum is shown at 3450, 1705 cm -1 .
3)紫外線吸収スペクトル(エタノール)分析 4)1H核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。3) Ultraviolet absorption spectrum (ethanol) analysis 4) 1 H nuclear magnetic resonance spectrum (CDCl 3 ) analysis Shows the following signals (δ, ppm).
4.96(1H,多重線)(3位のH) 4.81(1H,二重線,J=4.95Hz)(14位のH) 4.53(1H,二重線,J=5.94Hz)(15位のH) 4.11(1H,二重線,J=6.60Hz)(6位のH) 3.86(3H,一重線)(アニソイル基のメトキシ基の
H) 2.08(3H,一重線)(3位に結合したアセチル基のメ
チル基のH) 1.13(3H,三重線,J=7.26Hz)(N−エチル基のメチ
ル基のH) 0.64(3H,三重線,J=7.26Hz)(8位に結合したエト
キシ基のメチル基のH) 5)13C核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。 4.96 (1H, multiple line) (3rd H) 4.81 (1H, double line, J = 4.95Hz) (14th H) 4.53 (1H, double line, J = 5.94Hz) (15th H) ) 4.11 (1H, doublet, J = 6.60Hz) (H at 6th position) 3.86 (3H, singlet) (H of methoxy group of anisoyl group) 2.08 (3H, singlet) (H of the methyl group of the acetyl group bonded to the 3-position) 1.13 (3H, triplet, J = 7.26Hz) (H of the methyl group of the N-ethyl group) 0.64 (3H, triplet , J = 7.26 Hz) (H of the methyl group of the ethoxy group bonded to the 8-position) 5) 13 C Nuclear magnetic resonance spectrum (CDCl 3 ) analysis The following signals are shown (δ, ppm).
170.2(3位に結合したアセチル基のカルボニル基の
C) 166.0(14位のアニソイル基由来のカルボニル基の
C) 163.2,131.7,122.8,113.6(アニソイル基のC) 93.5,83.3,82.1,79.1,78.3,77.0,74.8,71.7(16,6,1,
8,14,15,18,13,3位のC) 62.2,58.7,55.4(16,18,6,1に結合したメトキシ基の
C) 56.4(アニソイル基のメトキシ基のC) 57.1(8位に結合したエトキシ基のメチレン基のC) 49.2(N−エチル基のメチレン基のC) 21.2(3位に結合したアセチル基のメチル基のC) 15.4(8位に結合したエトキシ基のメチル基のC) 13.3(N−エチル基のメチル基のC) 6)EI−質量スペクトル分析 m/z 703(M+) 7)高分解能質量スペクトル分析 計算値:703.356(C37H53NO12) 実測値:703.359 (15)3-O−アセチル−14−アニソイルアコニンの物性
値および分析データ 1)性状および溶解性 無色の非結晶性粉末でエーテル、クロロホルム、ベン
ゼン、エタノール、メタノール、アセトン、酢酸エチ
ル、ピリジン、ジメチルスルホキシドに可溶で、ヘキサ
ン、水に不溶である。170.2 (C of carbonyl group of acetyl group bonded to 3-position) 166.0 (C of carbonyl group derived from anisoyl group of 14-position) 163.2,131.7,122.8,113.6 (C of anisoyl group) 93.5,83.3,82.1,79.1, 78.3,77.0,74.8,71.7 (16,6,1,
8,14,15,18,13,3 position C) 62.2,58.7,55.4 (C of methoxy group bonded to 16,18,6,1) 56.4 (C of anisoyl group methoxy group) 57.1 (8 position Methylene group C of ethoxy group bound to 4) (Methylene group C of N-ethyl group) 21.2 (Acetyl methyl group C bound to 3-position) 15.4 (Ethoxy group methyl group bound to 8th position) C) 13.3 (C of methyl group of N-ethyl group) 6) EI-mass spectrum analysis m / z 703 (M + ) 7) High resolution mass spectrum analysis Calculated value: 703.356 (C 37 H 53 NO 12 ) Actual measurement Value: 703.359 (15) Physical properties and analytical data of 3-O-acetyl-14-anisoylaconine 1) Properties and solubility Colorless amorphous powder, ether, chloroform, benzene, ethanol, methanol, acetone, acetic acid. Soluble in ethyl, pyridine and dimethylsulfoxide, but insoluble in hexane and water.
2)赤外線吸収スペクトル(KBr)分析 3420,1710cm-1に吸収の極大を示す。2) Infrared absorption spectrum (KBr) analysis The maximum absorption is shown at 3420,1710 cm -1 .
3)紫外線吸収スペクトル(エタノール)分析 4)1H核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。3) Ultraviolet absorption spectrum (ethanol) analysis 4) 1 H nuclear magnetic resonance spectrum (CDCl 3 ) analysis Shows the following signals (δ, ppm).
4.97(1H,二重線,J=4.95Hz)(14位のH) 4.55(1H,二重線,J=5.60Hz)(15位のH) 4.07(1H,二重線,J=6.27Hz)(6位のH) 3.85(3H,一重線)(アニソイル基のメトキシ基の
H) 1.16(3H,三重線,J=6.93Hz)(N−エチル基のメチ
ル基のH) 5)13C核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。 4.97 (1H, double wire, J = 4.95Hz) (14th H) 4.55 (1H, double wire, J = 5.60Hz) (15th H) 4.07 (1H, double wire, J = 6.27Hz ) (H at 6th position) 3.85 (3H, singlet) (H at methoxy group of anisoyl group) 1.16 (3 H, triplet, J = 6.93 Hz) (H of methyl group of N-ethyl group) 5) 13 C Nuclear magnetic resonance spectrum (CDCl 3 ) analysis The following signals are shown (δ, ppm).
170.3(3位に結合したアセチル基のカルボニル基の
C) 165.9(14位のアニソイル基由来のカルボニル基の
C) 163.5,131.8,122.1,113.6(アニソイル基のC) 90.7,83.5,82.4,81.9,79.5,78.6,77.3,78.8,71.3(1
6,6,1,15,14,8,18,13,3位のC) 62.2,58.7,55.4(16,18,6,1に結合したメトキシ基の
C) 56.4(アニソイル基のメトキシ基のC) 49.0(N−エチル基のメチレン基のC) 21.1(3位に結合したアセチル基のメチル基のC) 13.0(N−エチル基のメチル基のC) 6)EI−質量スペクトル分析 m/z 675(M+) (16)8−O−メチル−14−ベンゾイルヒパコニンの物
性値および分析データ 1)性状および溶解性 無色の非結晶性粉末でエーテル、クロロホルム、ベン
ゼン、エタノール、メタノール、アセトン、酢酸エチ
ル、ピリジン、ジメチルスルホキシドに可溶で、ヘキサ
ン、水に不溶である。170.3 (C of carbonyl group of acetyl group bonded to 3-position) 165.9 (C of carbonyl group derived from anisoyl group of 14-position) 163.5,131.8,122.1,113.6 (C of anisoyl group) 90.7,83.5,82.4,81.9, 79.5,78.6,77.3,78.8,71.3 (1
6,6,1,15,14,8,18,13,3 position C) 62.2,58.7,55.4 (C of methoxy group bonded to 16,18,6,1) 56.4 (of methoxy group of anisoyl group) C) 49.0 (C of methylene group of N-ethyl group) 21.1 (C of methyl group of acetyl group bonded to 3-position) 13.0 (C of methyl group of N-ethyl group) 6) EI-mass spectrum analysis m / z 675 (M + ) (16) Physical properties and analytical data of 8-O-methyl-14-benzoylhypaconine 1) Properties and solubility Colorless amorphous powder of ether, chloroform, benzene, ethanol, methanol, Soluble in acetone, ethyl acetate, pyridine and dimethylsulfoxide, but insoluble in hexane and water.
2)赤外線吸収スペクトル(KBr)分析 3500,1710cm-1に吸収の極大を示す。2) Infrared absorption spectrum (KBr) analysis The maximum absorption is shown at 3500,1710 cm -1 .
3)紫外線吸収スペクトル(エタノール)分析 4)1H核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。3) Ultraviolet absorption spectrum (ethanol) analysis 4) 1 H nuclear magnetic resonance spectrum (CDCl 3 ) analysis Shows the following signals (δ, ppm).
8.10-7.45(5H,多重線)(ベンゾイル基のH) 4.70(1H,二重線,J=4.50Hz)(14位のH) 4.54(1H,二重線,J=5.93Hz)(15位のH) 4.06(1H,二重線,J=6.70Hz)(6位のH) 2.37(3H,一重線)(N−メチル基のH) 5)13C核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。8.10-7.45 (5H, multiple line) (H of benzoyl group) 4.70 (1H, double line, J = 4.50Hz) (H at 14th position) 4.54 (1H, double line, J = 5.93Hz) (15th position) H) 4.06 (1H, double wire, J = 6.70Hz) (6th H) 2.37 (3H, singlet) (H of N-methyl group) 5) 13 C Nuclear magnetic resonance spectrum (CDCl 3 ) analysis The following signals are shown (δ, ppm).
166.2(14位のベンゾイル基由来のカルボニル基の
C) 132.8,130.1,129.6,128.3(ベンゾイル基のC) 93.4,83.1,82.6,82.1,79.4,77.5,74.3(16,6,8,14,1
5,18,13位のC) 62.3,59.1,58.5,56.3(16,18,6,1位に結合したメトキ
シ基のC) 49.9(8位に結合したメトキシ基のC) 42.4(N−メチル基のC) 6)EI−質量スペクトル分析 m/z 587(M+) (17)8−O−エチル−14−ベンゾイルヒパコニンの物
性値および分析データ 1)性状および溶解性 無色の非結晶性粉末でエーテル、クロロホルム、ベン
ゼン、エタノール、メタノール、アセトン、酢酸エチ
ル、ピリジン、ジメチルスルホキシドに可溶で、ヘキサ
ン、水に不溶である。166.2 (C of carbonyl group derived from benzoyl group at 14-position) 132.8,130.1,129.6,128.3 (C of benzoyl group) 93.4,83.1,82.6,82.1,79.4,77.5,74.3 (16,6,8,14,1
5,18,13 position C) 62.3,59.1,58.5,56.3 (C of methoxy group bonded to 16,18,6,1 position) 49.9 (C of methoxy group bonded to 8 position) 42.4 (N-methyl Group C) 6) EI-mass spectrum analysis m / z 587 (M + ) (17) 8-O-ethyl-14-benzoylhypaconine physical properties and analytical data 1) Properties and solubility Colorless non-crystalline It is a soluble powder, soluble in ether, chloroform, benzene, ethanol, methanol, acetone, ethyl acetate, pyridine and dimethylsulfoxide, but insoluble in hexane and water.
2)赤外線吸収スペクトル(KBr)分析 3450,1715cm-1に吸収の極大を示す。2) Infrared absorption spectrum (KBr) analysis The absorption maximum is shown at 3450,1715 cm -1 .
3)紫外線吸収スペクトル(エタノール)分析 4)1H核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。3) Ultraviolet absorption spectrum (ethanol) analysis 4) 1 H nuclear magnetic resonance spectrum (CDCl 3 ) analysis Shows the following signals (δ, ppm).
8.07-7.26(5H,多重線)(ベンゾイル基のH) 4.82(1H,二重線,J=4.50Hz)(14位のH) 4.55(1H,二重線,J=5.93Hz)(15位のH) 4.08(1H,二重線,J=6.70Hz)(6位のH) 2.34(3H,一重線)(N−メチル基のH) 0.58(1H,三重線,J=6.00Hz)(8位に結合したエト
キシ基のH) 5)13C核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。8.07-7.26 (5H, multiple line) (H of benzoyl group) 4.82 (1H, double line, J = 4.50Hz) (14th H) 4.55 (1H, double line, J = 5.93Hz) (15th place) H) 4.08 (1H, double line, J = 6.70Hz) (6th H) 2.34 (3H, singlet) (H of N-methyl group) 0.58 (1H, triplet, J = 6.00Hz) (H of ethoxy group bonded to 8-position) 5) 13 C Nuclear magnetic resonance spectrum (CDCl 3 ) Analysis The following signals are shown (δ, ppm).
166.1(14位のベンゾイル基由来のカルボニル基の
C) 132.8,130.3,129.6,128.3(ベンゾイル基のC) 93.5,83.2,82.6,81.9,79.4,78.3,74.7(16,6,8,14,1
5,18,13位のC) 62.4,59.1,58.6,56.3(16,18,6,1位に結合したメトキ
シ基のC) 57.2(8位に結合したエトキシ基のメチレン基のC) 42.5(N−メチル基のC) 15.3(8位に結合したエトキシ基のメチル基のC) 6)EI−質量スペクトル分析 m/z 599(M+) (18)8-O−アミル−14−ベンゾイルアコニンの物性値
および分析データ 1)性状および溶解性 無色の非結晶性粉末でエーテル、クロロホルム、ベン
ゼン、エタノール、メタノール、アセトン、酢酸エチ
ル、ピリジン、ジメチルスルホキシドに可溶で、ヘキサ
ン、水に不溶である。166.1 (C of carbonyl group derived from benzoyl group at 14-position) 132.8,130.3,129.6,128.3 (C of benzoyl group) 93.5,83.2,82.6,81.9,79.4,78.3,74.7 (16,6,8,14,1
5,18,13 position C) 62.4,59.1,58.6,56.3 (C of methoxy group bonded to 16,18,6,1 position) 57.2 (C of methylene group of ethoxy group bonded to 8 position) 42.5 ( C of N-methyl group) 15.3 (C of methyl group of ethoxy group bonded to 8-position) 6) EI-mass spectrum analysis m / z 599 (M + ) (18) 8-O-amyl-14-benzoyl aco Physical properties and analytical data of nin 1) Properties and solubility It is a colorless amorphous powder, soluble in ether, chloroform, benzene, ethanol, methanol, acetone, ethyl acetate, pyridine and dimethyl sulfoxide, but insoluble in hexane and water. is there.
2)赤外線吸収スペクトル(KBr)分析 3400,1715cm-1に吸収の極大を示す。2) Infrared absorption spectrum (KBr) analysis The maximum absorption is shown at 3400,1715 cm -1 .
3)紫外線吸収スペクトル(エタノール)分析 4)1H核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。3) Ultraviolet absorption spectrum (ethanol) analysis 4) 1 H nuclear magnetic resonance spectrum (CDCl 3 ) analysis Shows the following signals (δ, ppm).
8.06-7.41(5H,多重線)(ベンゾイル基のH) 4.83(1H,二重線,J=4.95Hz)(14位のH) 4.56(1H,二重線,J=5.93Hz)(15位のH) 4.09(1H,二重線,J=6.59Hz)(6位のH) 1.13(3H,三重線,J=7.26Hz)(N−エチル基のメチ
ル基のH) 0.57(3H,三重線,J=6.29Hz)(8位に結合したアミ
ル基のメチル基のH) 5)13C核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。8.06-7.41 (5H, multiple line) (H of benzoyl group) 4.83 (1H, double line, J = 4.95Hz) (H in 14th position) 4.56 (1H, double line, J = 5.93Hz) (15th position) H) 4.09 (1H, double wire, J = 6.59Hz) (H in 6th place) 1.13 (3H, triplet, J = 7.26Hz) (H of methyl group of N-ethyl group) 0.57 (3H, triplet, J = 6.29Hz) (H of methyl group of amyl group bonded to 8th position) 5 ) 13 C nuclear magnetic resonance spectrum (CDCl 3 ) analysis shows the following signals (δ, ppm).
166.1(14位のベンゾイル基由来のカルボニル基の
C) 132.8,130.2,129.6,128.3(ベンゾイル基のC) 93.2,83.3,82.3,82.2,79.4,76.8,74.7,71.5(16,6,1,
8,14,15,18,13,3位のC) 62.3,59.0,58.5,55.7(16,18,6,1に結合したメトキシ
基のC) 57.5(8位に結合したアミル基のメチレン基のC) 48.9(N−エチル基のメチレン基のC) 15.0(8位に結合したアミル基のメチレン基のC) 13.1(N−エチル基のメチル基のC) 6)EI−質量スペクトル分析 m/z 675(M+) (19)3−O−アセチル−8−O−アミル−14−ベンゾ
イルアコニンの物性値および分析データ 1)性状および溶解性 無色の非結晶性粉末でエーテル、クロロホルム、ベン
ゼン、エタノール、メタノール、アセトン、酢酸エチ
ル、ピリジン、ジメチルスルホキシドに可溶で、ヘキサ
ン、水に不溶である。166.1 (C of carbonyl group derived from benzoyl group at 14-position) 132.8,130.2,129.6,128.3 (C of benzoyl group) 93.2,83.3,82.3,82.2,79.4,76.8,74.7,71.5 (16,6,1,
8,14,15,18,13,3 position C) 62.3,59.0,58.5,55.7 (C of methoxy group bonded to 16,18,6,1) 57.5 (methylene group of amyl group bonded to 8 position) C) 48.9 (C of methylene group of N-ethyl group) 15.0 (C of methylene group of amyl group bonded to 8-position) 13.1 (C of methyl group of N-ethyl group) 6) EI-mass spectrum analysis m / z 675 (M + ) (19) 3-O-acetyl-8-O-amyl-14-benzoylaconine physical properties and analytical data 1) Properties and solubility Colorless amorphous powder of ether, chloroform, Soluble in benzene, ethanol, methanol, acetone, ethyl acetate, pyridine and dimethylsulfoxide, but insoluble in hexane and water.
2)赤外線吸収スペクトル(KBr)分析 3500,1720cm-1に吸収の極大を示す。2) Infrared absorption spectrum (KBr) analysis The maximum absorption is shown at 3500 and 1720 cm -1 .
3)紫外線吸収スペクトル(エタノール)分析 4)1H核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。3) Ultraviolet absorption spectrum (ethanol) analysis 4) 1 H nuclear magnetic resonance spectrum (CDCl 3 ) analysis Shows the following signals (δ, ppm).
8.06-7.41(5H,多重線)(ベンゾイル基のH) 4.97(1H,多重線)(3位のH) 4.82(1H,二重線,J=4.95Hz)(14位のH) 4.53(1H,二重線,J=5.94Hz)(15位のH) 4.18(1H,二重線,J=6.59Hz)(6位のH) 2.07(3H,一重線)(3位に結合したアセチル基のメ
チル基のH) 1.11(3H,三重線,J=7.09Hz)(N−エチル基のメチ
ル基のH) 0.55(3H,三重線,J=6.76Hz)(8位に結合したアミ
ル基のメチル基のH) 5)13C核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。8.06-7.41 (5H, multiplex) (benzoyl group H) 4.97 (1H, multiplex) (3rd position H) 4.82 (1H, double line, J = 4.95Hz) (14th position H) 4.53 (1H , Double wire, J = 5.94Hz) (15th place H) 4.18 (1H, double wire, J = 6.59Hz) (6th place H) 2.07 (3H, singlet) (H of methyl group of acetyl group bonded to 3-position) 1.11 (3H, triplet, J = 7.09Hz) (H of methyl group of N-ethyl group) 0.55 (3H, triplet , J = 6.76 Hz) (H of the methyl group of the amyl group bonded to the 8-position) 5) 13 C nuclear magnetic resonance spectrum (CDCl 3 ) analysis The following signals are shown (δ, ppm).
170.2(3位に結合したアセチル基のカルボニル基の
C) 166.2(14位のベンゾイル基由来のカルボニル基の
C) 132.7,130.3,129.6,128.2(ベンゾイル基のC) 93.6,83.4,82.3,82.0,79.5,78.5,77.0,74.8,71.5(1
6,6,1,8,14,15,18,13,3位のC) 62.3,60.9,58.7,56.4(16,18,6,1に結合したメトキシ
基のC) 57.0(8位に結合したアミル基のメチレン基のC) 49.1(N−エチル基のメチレン基のC) 21.2(3位に結合したアセチル基のメチル基のC) 15.0(8位に結合したアミル基のメチル基のC) 13.5(N−エチル基のメチル基のC) 6)EI−質量スペクトル分析 m/z 717(M+) (20)8−O−アミル−14−ベンゾイルメサコニンの物
性値および分析データ 1)性状および溶解性 無色の非結晶性粉末でエーテル、クロロホルム、ベン
ゼン、エタノール、メタノール、アセトン、酢酸エチ
ル、ピリジン、ジメチルスルホキシドに可溶で、ヘキサ
ン、水に不溶である。170.2 (C of carbonyl group of acetyl group bonded to 3-position) 166.2 (C of carbonyl group derived from benzoyl group of 14-position) 132.7, 130.3, 129.6, 128.2 (C of benzoyl group) 93.6, 83.4, 82.3, 82.0, 79.5,78.5,77.0,74.8,71.5 (1
6,6,1,8,14,15,18,13,3 position C) 62.3,60.9,58.7,56.4 (C of methoxy group bonded to 16,18,6,1) 57.0 (bonded to 8 position 49.1 (C of methylene group of N-ethyl group) 21.2 (C of methyl group of acetyl group bonded to 3-position) 15.0 (C of methyl group of amyl group bonded to 8-position) ) 13.5 (C of methyl group of N-ethyl group) 6) EI-mass spectrum analysis m / z 717 (M + ) (20) 8-O-amyl-14-benzoyl mesaconiine physical properties and analytical data 1) Properties and solubility A colorless, amorphous powder that is soluble in ether, chloroform, benzene, ethanol, methanol, acetone, ethyl acetate, pyridine, and dimethyl sulfoxide, but insoluble in hexane and water.
2)赤外線吸収スペクトル(KBr)分析 3450,1715cm-1に吸収の極大を示す。2) Infrared absorption spectrum (KBr) analysis The absorption maximum is shown at 3450,1715 cm -1 .
3)紫外線吸収スペクトル(エタノール)分析 4)1H核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。3) Ultraviolet absorption spectrum (ethanol) analysis 4) 1 H nuclear magnetic resonance spectrum (CDCl 3 ) analysis Shows the following signals (δ, ppm).
8.08-7.27(5H,多重線)(ベンゾイル基のH) 4.81(1H,二重線,J=4.70Hz)(14位のH) 4.54(1H,二重線,J=6.10Hz)(15位のH) 4.08(1H,二重線,J=7.60Hz)(6位のH) 2.34(3H,一重線)(N−メチル基のH) 0.55(3H,三重線,J=6.00Hz)(8位に結合したアミ
ル基のメチル基のH) 5)13C核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。8.08-7.27 (5H, multiple line) (H of benzoyl group) 4.81 (1H, double line, J = 4.70Hz) (H at 14th position) 4.54 (1H, double line, J = 6.10Hz) (15th position) H) 4.08 (1H, double wire, J = 7.60Hz) (6th H) 2.34 (3H, singlet) (H of N-methyl group) 0.55 (3H, triplet, J = 6.00Hz) (H of methyl group of amyl group bound to 8-position) 5) 13 C Nuclear magnetic resonance spectrum ( CDCl 3 ) analysis shows the following signals (δ, ppm).
166.1(14位のベンゾイル基由来のカルボニル基の
C) 132.8,130.3,129.6,128.2(ベンゾイル基のC) 93.4,83.3,82.7,82.0,79.4,78.3,76.4,74.7,71.3(1
6,6,1,8,14,15,18,13,3位のC) 62.4,59.1,58.6,56.3(16,18,6,1に結合したメトキシ
基のC) 57.0(8位に結合したアミル基のメチレン基のC) 42.5(N−メチル基のC) 15.1(8位に結合したアミル基のメチル基のC) 6)EI−質量スペクトル分析 m/z 661(M+) (21)3−O−アセチル−8−O−アミル−14−ベンゾ
イルメサコニンの物性値および分析データ 1)性状および溶解性 無色の非結晶性粉末でエーテル、クロロホルム、ベン
ゼン、エタノール、メタノール、アセトン、酢酸エチ
ル、ピリジン、ジメチルスルホキシドに可溶で、ヘキサ
ン、水に不溶である。166.1 (C of carbonyl group derived from benzoyl group at 14-position) 132.8,130.3,129.6,128.2 (C of benzoyl group) 93.4,83.3,82.7,82.0,79.4,78.3,76.4,74.7,71.3 (1
6,6,1,8,14,15,18,13,3 position C) 62.4,59.1,58.6,56.3 (C of methoxy group bonded to 16,18,6,1) 57.0 (bonded to 8 position Methylene group C of amyl group 42.5 (C of N-methyl group) 15.1 (C of amyl group methyl group attached to 8-position) 6) EI-mass spectrum analysis m / z 661 (M + ) (21 ) Physical properties and analytical data of 3-O-acetyl-8-O-amyl-14-benzoylmethaconine 1) Properties and solubility Colorless amorphous powder of ether, chloroform, benzene, ethanol, methanol, acetone, acetic acid. Soluble in ethyl, pyridine and dimethylsulfoxide, but insoluble in hexane and water.
2)赤外線吸収スペクトル(KBr)分析 3500,1720cm-1に吸収の極大を示す。2) Infrared absorption spectrum (KBr) analysis The maximum absorption is shown at 3500 and 1720 cm -1 .
3)紫外線吸収スペクトル(エタノール)分析 4)1H核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。3) Ultraviolet absorption spectrum (ethanol) analysis 4) 1 H nuclear magnetic resonance spectrum (CDCl 3 ) analysis Shows the following signals (δ, ppm).
8.06-7.41(5H,多重線)(ベンゾイル基のH) 4.96(1H,多重線)(3位のH) 4.82(1H,二重線,J=4.95Hz)(14位のH) 4.54(1H,二重線,J=5.94Hz)(15位のH) 4.14(1H,二重線,J=6.92Hz)(6位のH) 2.08(3H,一重線)(3位に結合したアセチル基のメ
チル基のH) 0.55(3H,三重線,J=6.92Hz)(8位に結合したアミ
ル基のメチル基のH) 5)13C核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。8.06-7.41 (5H, multiplet) (H of benzoyl group) 4.96 (1H, multiplet) (H of 3rd position) 4.82 (1H, doublet, J = 4.95Hz) (H of 14th position) 4.54 (1H , Double wire, J = 5.94Hz) (15th H) 4.14 (1H, double wire, J = 6.92Hz) (6th H) 2.08 (3H, singlet) (H of methyl group of acetyl group bonded to 3-position) 0.55 (3H, triplet, J = 6.92Hz) (H of methyl group of amyl group bonded to 8-position) 5) 13 C nuclear magnetic resonance spectrum (CDCl 3 ) analysis shows the following signals (δ, ppm).
170.2(3位に結合したアセチル基のカルボニル基の
C) 166.2(14位のベンゾイル基由来のカルボニル基の
C) 132.8,129.6,128.2(ベンゾイル基のC) 93.3,82.0,79.3,78.3,77.4,74.6,71.4(16,6,1,8,14,
15,18,13,3位のC) 62.1,58.8,56.6(16,18,6,1に結合したメトキシ基の
C) 57.0(8位に結合したアミル基のメチレン基のC) 42.6(N−メチル基のC) 21.2(3位に結合したアセチル基のメチル基のC) 15.2(8位に結合したアミル基のメチル基のC) 6)EI−質量スペクトル分析 m/z 703(M+) (22)8−O−アミル−14−アニソイルアコニンの物性
値および分析データ 1)性状および溶解性 無色の非結晶性粉末でエーテル、クロロホルム、ベン
ゼン、エタノール、メタノール、アセトン、酢酸エチ
ル、ピリジン、ジメチルスルホキシドに可溶で、ヘキサ
ン、水に不溶である。170.2 (C of carbonyl group of acetyl group bonded to 3-position) 166.2 (C of carbonyl group derived from benzoyl group of 14-position) 132.8,129.6,128.2 (C of benzoyl group) 93.3,82.0,79.3,78.3,77.4, 74.6,71.4 (16,6,1,8,14,
15,18,13,3 position C) 62.1,58.8,56.6 (C of methoxy group bonded to 16,18,6,1) 57.0 (C of amyl group methylene group bonded to 8 position) 42.6 (N -C of methyl group 21.2 (C of methyl group of acetyl group bonded to 3-position) 15.2 (C of methyl group of amyl group bonded to 8-position) 6) EI-mass spectrum analysis m / z 703 (M + ) (22) Physical properties and analytical data of 8-O-amyl-14-anisoylaconine 1) Properties and solubility A colorless amorphous powder of ether, chloroform, benzene, ethanol, methanol, acetone, ethyl acetate, Soluble in pyridine and dimethyl sulfoxide, but insoluble in hexane and water.
2)赤外線吸収スペクトル(KBr)分析 3450,1720cm-1に吸収の極大を示す。2) Infrared absorption spectrum (KBr) analysis The absorption maximum is shown at 3450 and 1720 cm -1 .
3)紫外線吸収スペクトル(エタノール)分析 4)1H核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。3) Ultraviolet absorption spectrum (ethanol) analysis 4) 1 H nuclear magnetic resonance spectrum (CDCl 3 ) analysis Shows the following signals (δ, ppm).
4.60(1H,二重線,J=6.00Hz)(14位のH) 3.88(3H,一重線)(アニソイル基のメトキシ基の
H) 1.11(3H,三重線,J=7.00Hz)(N−エチル基のメチ
ル基のH) 0.54(3H,三重線,J=6.00Hz)(8位に結合したアミ
ル基のメチル基のH) 5)13C核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。 4.60 (1H, doublet, J = 6.00Hz) (H at 14th position) 3.88 (3H, singlet) (H of methoxy group of anisoyl group) 1.11 (3H, triplet, J = 7.00Hz) (H of methyl group of N-ethyl group) 0.54 (3H, triplet, J = 6.00Hz) (H of methyl group of amyl group bonded to 8-position) 5 ) 13 C nuclear magnetic resonance spectrum (CDCl 3 ) analysis shows the following signals (δ, ppm).
165.8(14位のアニソイル基由来のカルボニル基の
C) 163.1,131.6,122.7,113.6(アニソイル基のC) 93.3,83.4,82.5,82.1,79.2,77.3,74.2,71.6(16,6,1,
8,14,15,18,13,3位のC) 62.3,59.0,58.5,55.8(16,18,6,1に結合したメトキシ
基のC) 55.3(アニソイル基のメトキシ基のC) 57.1(8位に結合したアミル基のメチレン基のC) 48.8(N−エチル基のメチレン基のC) 15.3(8位に結合したアミル基のメチル基のC) 13.0(N−エチル基のメチル基のC) 6)EI−質量スペクトル分析 m/z 705(M+) (23)3−O−アセチル−8−O−アミル−14−アニソ
イルアコニンの物性値および分析データ 1)性状および溶解性 無色の非結晶性粉末でエーテル、クロロホルム、ベン
ゼン、エタノール、メタノール、アセトン、酢酸エチ
ル、ピリジン、ジメチルスルホキシドに可溶で、ヘキサ
ン、水に不溶である。165.8 (C of carbonyl group derived from 14th anisoyl group) 163.1,131.6,122.7,113.6 (C of anisoyl group) 93.3,83.4,82.5,82.1,79.2,77.3,74.2,71.6 (16,6,1,
8,14,15,18,13,3 position C) 62.3,59.0,58.5,55.8 (C of the methoxy group bonded to 16,18,6,1) 55.3 (C of the methoxy group of anisoyl group) 57.1 ( C8 of the methylene group of the amyl group bonded to the 8-position 48.8 (C of the methylene group of the N-ethyl group) 15.3 (C of the methyl group of the amyl group bonded to the 8-position) 13.0 (of the methyl group of the N-ethyl group) C) 6) EI-mass spectrum analysis m / z 705 (M + ) (23) 3-O-acetyl-8-O-amyl-14-anisoylaconine Physical properties and analytical data 1) Properties and solubility It is a colorless amorphous powder that is soluble in ether, chloroform, benzene, ethanol, methanol, acetone, ethyl acetate, pyridine, and dimethylsulfoxide, but insoluble in hexane and water.
2)赤外線吸収スペクトル(KBr)分析 3450,1705cm-1に吸収の極大を示す。2) Infrared absorption spectrum (KBr) analysis The absorption maximum is shown at 3450, 1705 cm -1 .
3)紫外線吸収スペクトル(エタノール)分析 4)1H核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。3) Ultraviolet absorption spectrum (ethanol) analysis 4) 1 H nuclear magnetic resonance spectrum (CDCl 3 ) analysis Shows the following signals (δ, ppm).
4.96(1H,多重線)(3位のH) 4.81(1H,二重線,J=4.95Hz)(14位のH) 4.53(1H,二重線,J=5.94Hz)(15位のH) 4.11(1H,二重線,J=6.60Hz)(6位のH) 3.86(3H,一重線)(アニソイル基のメトキシ基の
H) 2.08(3H,一重線)(3位に結合したアセチル基のメ
チル基のH) 1.13(3H,三重線,J=7.26Hz)(N−エチル基のメチ
ル基のH) 0.55(3H,三重線,J=7.26Hz)(8位に結合したアミ
ル基のメチル基のH) 5)13C核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。 4.96 (1H, multiple line) (3rd H) 4.81 (1H, double line, J = 4.95Hz) (14th H) 4.53 (1H, double line, J = 5.94Hz) (15th H) ) 4.11 (1H, doublet, J = 6.60Hz) (H at 6th position) 3.86 (3H, singlet) (H of methoxy group of anisoyl group) 2.08 (3H, singlet) (H of the methyl group of the acetyl group bonded to the 3-position) 1.13 (3H, triplet, J = 7.26Hz) (H of the methyl group of the N-ethyl group) 0.55 (3H, triplet , J = 7.26 Hz) (H of the methyl group of the amyl group bonded to the 8-position) 5) 13 C nuclear magnetic resonance spectrum (CDCl 3 ) analysis The following signals are shown (δ, ppm).
170.2(3位に結合したアセチル基のカルボニル基の
C) 166.0(14位のアニソイル基由来のカルボニル基の
C) 163.2,131.7,122.8,113.6(アニソイル基のC) 93.5,83.3,82.1,79.1,78.3,77.0,74.8,71.7(16,6,1,
8,14,15,18,13,3位のC) 62.2,58.7,55.4(16,18,6,1に結合したメトキシ基の
C) 56.4(アニソイル基のメトキシ基のC) 57.1(8位に結合したアミル基のメチレン基のC) 49.2(N−エチル基のメチレン基のC) 21.2(3位に結合したアセチル基のメチル基のC) 15.1(8位に結合したアミル基のメチル基のC) 13.3(N−エチル基のメチル基のC) 6)EI−質量スペクトル分析 m/z 733(M+) (24)8−O−アミル−14−ベンゾイルヒパコニンの物
性値および分析データ 1)性状および溶解性 無色の非結晶性粉末でエーテル、クロロホルム、ベン
ゼン、エタノール、メタノール、アセトン、酢酸エチ
ル、ピリジン、ジメチルスルホキシドに可溶で、ヘキサ
ン、水に不溶である。170.2 (C of carbonyl group of acetyl group bonded to 3-position) 166.0 (C of carbonyl group derived from anisoyl group of 14-position) 163.2,131.7,122.8,113.6 (C of anisoyl group) 93.5,83.3,82.1,79.1, 78.3,77.0,74.8,71.7 (16,6,1,
8,14,15,18,13,3 position C) 62.2,58.7,55.4 (C of methoxy group bonded to 16,18,6,1) 56.4 (C of anisoyl group methoxy group) 57.1 (8 position Methylene group C of the amyl group bonded to 4) (methylene group C of the N-ethyl group) 21.2 (acetyl group methyl group C bonded to the 3-position) 15.1 (amyl group methyl group bonded to the 8-position) C) 13.3 (C of methyl group of N-ethyl group) 6) EI-mass spectroscopic analysis m / z 733 (M + ) (24) 8-O-amyl-14-benzoylhypaconine Data 1) Properties and solubility It is a colorless amorphous powder which is soluble in ether, chloroform, benzene, ethanol, methanol, acetone, ethyl acetate, pyridine and dimethylsulfoxide, but insoluble in hexane and water.
2)赤外線吸収スペクトル(KBr)分析 3450,1715cm-1に吸収の極大を示す。2) Infrared absorption spectrum (KBr) analysis The absorption maximum is shown at 3450,1715 cm -1 .
3)紫外線吸収スペクトル(エタノール)分析 4)1H核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。3) Ultraviolet absorption spectrum (ethanol) analysis 4) 1 H nuclear magnetic resonance spectrum (CDCl 3 ) analysis Shows the following signals (δ, ppm).
8.07-7.26(5H,多重線)(ベンゾイル基のH) 4.82(1H,二重線,J=4.50Hz)(14位のH) 4.55(1H,二重線,J=5.93Hz)(15位のH) 4.08(1H,二重線,J=6.70Hz)(6位のH) 2.34(3H,一重線)(N−メチル基のH) 0.55(3H,三重線,J=6.00Hz)(8位に結合したアミ
ル基のメチル基のH) 5)13C核磁気共鳴スペクトル(CDCl3)分析 次のシグナルを示す(δ,ppm)。8.07-7.26 (5H, multiple line) (H of benzoyl group) 4.82 (1H, double line, J = 4.50Hz) (14th H) 4.55 (1H, double line, J = 5.93Hz) (15th place) H) 4.08 (1H, double line, J = 6.70Hz) (6th H) 2.34 (3H, singlet) (H of N-methyl group) 0.55 (3H, triplet, J = 6.00Hz) (H of methyl group of amyl group bound to 8-position) 5) 13 C Nuclear magnetic resonance spectrum ( CDCl 3 ) analysis shows the following signals (δ, ppm).
166.1(14位のベンゾイル基由来のカルボニル基の
C) 132.8,130.3,129.6,128.3(ベンゾイル基のC) 93.5,83.2,82.6,81.9,79.4,78.3,76.4,74.7(16,6,8,
14,15,18,13位のC) 62.4,59.1,58.6,56.3(16,18,6,1位に結合したメトキ
シ基のC) 57.0(8位に結合したアミル基のメチレン基のC) 42.5(N−エチル基のC) 15.0(8位に結合したアミル基のメチル基のC) 6)EI−質量スペクトル分析 m/z 643(M+) 本発明に係る化合物の薬理作用および急性毒性につい
ての実験例を示す。166.1 (C of carbonyl group derived from benzoyl group at 14-position) 132.8,130.3,129.6,128.3 (C of benzoyl group) 93.5,83.2,82.6,81.9,79.4,78.3,76.4,74.7 (16,6,8,
C at 14,15,18,13 position) 62.4,59.1,58.6,56.3 (C at methoxy group bonded to 16,18,6,1 position) 57.0 (C at methylene group of amyl group bonded at 8 position) 42.5 (C of N-ethyl group) 15.0 (C of methyl group of amyl group bonded to 8-position) 6) EI-mass spectrum analysis m / z 643 (M + ) Pharmacological action and acute toxicity of the compound according to the present invention An example of the experiment will be shown.
[実験例1](鎮痛作用) 酢酸ライシング法に基づく鎮痛活性の測定 実験にはStd:ddY系雄性マウス(20〜25g)を使用し
た。動物は室温24〜25℃,自由な摂食,摂水および12時
間周期の明暗条件下で飼育した。被検薬は3%アラビア
ゴム懸濁液として用いた。被検薬投与(s.c.)後30分に
0.7%酢酸/0.9%生理食塩液を10ml/kgの割合で腹腔内に
注射し,注射後10分から10分間に発現するライシング数
を数えた。陰性対照として3%アラビアゴム/0.9%生理
食塩液を使用した。また,ED50値は,陰性対照群のライ
シング数の1/2以下のものを鎮痛活性陽性とし,Litchfie
ld-Wilcoxon法に基づき算出した。その結果を表1に示
す。[Experimental Example 1] (Analgesic action) Measurement of analgesic activity based on acetic acid lysing method Male Std: ddY mice (20 to 25 g) were used for the experiment. The animals were kept at room temperature 24 to 25 ° C. under free feeding, watering and light / dark conditions with a 12-hour cycle. The test drug was used as a 3% gum arabic suspension. 30 minutes after test drug administration (sc)
0.7% acetic acid / 0.9% physiological saline solution was intraperitoneally injected at a rate of 10 ml / kg, and the number of licings developed 10 to 10 minutes after the injection was counted. As a negative control, 3% gum arabic / 0.9% saline solution was used. The ED 50 value was determined to be positive for analgesic activity when the licing number of the negative control group was 1/2 or less.
It was calculated based on the ld-Wilcoxon method. The results are shown in Table 1.
表1に示されているように,本発明に係る化合物は用
量依存的な鎮痛活性を有することが認められた。As shown in Table 1, the compound of the present invention was found to have a dose-dependent analgesic activity.
[実験例2](抗炎症作用) カラゲニン足蹠浮腫の測定 実験にはStd:ddY系雄性マウス(20〜25g)を使用し
た。薬物を経口投与後30分に0.9%生理食塩液に懸濁し
たカラゲニン(0.5mg/25μl)25μlを起炎剤としてマ
ウス右後肢足蹠皮下に注射した。対照として左後肢足蹠
皮下に0.9%生理食塩液25μlを注射した。足の厚さの
測定はダイヤルゲージキャリパーを用いて行い,カラゲ
ニン投与後1,2,3,4,5および6時間に測定した。結果
は,左右の足の厚さの差で表した。その結果を表2に示
す。 [Experimental Example 2] (Anti-inflammatory action) Measurement of carrageenin footpad edema Std: ddY male mice (20 to 25 g) were used in the experiment. Thirty minutes after oral administration of the drug, 25 μl of carrageenin (0.5 mg / 25 μl) suspended in 0.9% physiological saline was injected subcutaneously into the footpad of the right hind leg of a mouse as an inflammatory agent. As a control, 25 μl of 0.9% physiological saline was injected subcutaneously in the footpad of the left hind leg. The paw thickness was measured using a dial gauge caliper, and 1, 2, 3, 4, and 6 hours after carrageenin administration. The results were expressed as the difference in the thickness of the left and right feet. The results are shown in Table 2.
表2に示されているように,本発明に係る化合物はカ
ラゲニン足蹠浮腫抑制作用を有することが認められた。As shown in Table 2, it was confirmed that the compound according to the present invention has a carrageenin footpad edema inhibitory action.
[実験例3](急性毒性) 実験にはStd:ddY系雄性マウス(20〜25g)を使用し
た。被検薬投与後72時間の致死数からLitchfield-Wilco
xon法に基づきLD50値を算出した。その結果を表3に示
す。 [Experimental Example 3] (Acute toxicity) Male Std: ddY mice (20 to 25 g) were used in the experiment. Litchfield-Wilco from 72 hours after administration of the test drug
The LD 50 value was calculated based on the xon method. Table 3 shows the results.
表3に示されているように,本発明に係る化合物はメ
サコニチン,アコニチン,ヒパコニチンおよびジェサコ
ニチンに比べ,毒性が低下していることが認められた。As shown in Table 3, it was confirmed that the compound according to the present invention had reduced toxicity as compared with mesaconitine, aconitine, hypaconitine and gesaconitine.
以上,本発明に係る化合物はメサコニチン,アコニチ
ン,ヒパコニチンおよびジェサコニチンよりも毒性が低
く,また強力な鎮痛・抗炎症活性を有するものであるこ
とが明らかとなった。As described above, it was revealed that the compound according to the present invention is less toxic than mesaconitine, aconitine, hypaconitine and jesaconitine, and has a strong analgesic / anti-inflammatory activity.
本発明に係る鎮痛・抗炎症剤の臨床投与量は,活性成
分として成人0.01〜10mg/日が好ましい。本発明の製剤
は任意所要の製剤用担体あるいは賦形剤により慣用の方
法で使用に供される。The clinical dose of the analgesic / anti-inflammatory agent according to the present invention is preferably 0.01 to 10 mg / day for an adult as an active ingredient. The preparation of the present invention is provided for use in a conventional manner with any desired carrier or excipient for preparation.
経口投与用の錠剤,散剤,顆粒剤,カプセル等は慣用
の賦形剤,例えば炭酸カルシウム,炭酸マグネシウム,
リン酸カルシウム,とうもろこしでんぷん,ばれいしょ
でんぷん,砂糖,ラクトース,タルク,ステアリン酸マ
グネシウム,アラビアゴム等を含有していてもよい。錠
剤は周知の方法でコーティングしてもよい。経口用液体
製剤は水性または油性懸濁液,溶液,シロップ,エリキ
シル剤,その他であってもよい。Tablets, powders, granules, capsules, etc. for oral administration include conventional excipients such as calcium carbonate, magnesium carbonate,
It may contain calcium phosphate, corn starch, potato starch, sugar, lactose, talc, magnesium stearate, gum arabic and the like. The tablets may be coated by well known methods. Liquid oral preparations may be aqueous or oily suspensions, solutions, syrups, elixirs, and the like.
注射用製剤は,本発明に係る化合物は塩の形態で用い
てもよく,用時溶解型が好ましい。また,懸濁化剤,安
定剤または分散剤のような処方剤を含んでいてもよく,
滅菌蒸留水,精油たとえばピーナッツ油,とうもろこし
油あるいは非水溶媒,ポリエチレングリコール,ポリプ
ロピレングリコール等を含有していてもよい。In the injectable preparation, the compound according to the present invention may be used in the form of a salt, and the soluble form at the time of use is preferable. It may also contain formulating agents such as suspending, stabilizing or dispersing agents,
It may contain sterile distilled water, essential oil such as peanut oil, corn oil or non-aqueous solvent, polyethylene glycol, polypropylene glycol and the like.
直腸内投与のためには坐剤用組成物の形で提供され,
当業界において周知の製剤用担体,例えばポリエチレン
グリコール,ラノリン,ココナット油等を含有していて
もよい。Provided for the rectal administration in the form of a suppository composition,
It may contain a carrier for formulation well known in the art, such as polyethylene glycol, lanolin, coconut oil and the like.
局所適用のためには軟膏用組成物あるいは硬膏用組成
物の形で提供され,当業界において周知の製剤用担体,
例えばワセリン,パラフィン,加水ラノリン,プラスチ
ベース,親水ワセリン,マクロゴール類,ロウ,樹脂,
精製ラノリン,ゴムなどを含有していてもよい。For topical application, provided in the form of an ointment composition or a plaster composition, a carrier for formulation well known in the art,
For example, petrolatum, paraffin, hydrolanolate, plastibase, hydrophilic petrolatum, macrogol, wax, resin,
It may contain purified lanolin, rubber and the like.
Claims (2)
はエチル、R3は水酸基、アセチルオキシ又は水素、R4は
低級アルキル基又は水素を表す。但し、R1がベンゾイ
ル、R2がエチル、R3がアセチルオキシである場合はR4は
エチルではない。R1がベンゾイル、R2がメチル、R3が水
酸基である場合はR4はメチル、エチル又は水素ではな
い。R1がアニソイル、R2がエチル、R3が水酸基の場合は
R4はメチル、エチル又は水素ではない。R1がベンゾイ
ル、R2がメチル、R3が水素の場合はR4は水素ではない。
R1がベンゾイル、R2がエチル、R3が水酸基の場合はR4は
水素ではない。)で表されるアコニチン系化合物。1. A general formula, (In the formula, R 1 represents benzoyl or anisoyl, R 2 represents methyl or ethyl, R 3 represents a hydroxyl group, acetyloxy or hydrogen, R 4 represents a lower alkyl group or hydrogen, provided that R 1 is benzoyl and R 2 is ethyl. , R 3 is acetyloxy, R 4 is not ethyl R 1 is benzoyl, R 2 is methyl and R 3 is a hydroxyl group R 4 is not methyl, ethyl or hydrogen R 1 is anisoyl , R 2 is ethyl and R 3 is a hydroxyl group,
R 4 is not methyl, ethyl or hydrogen. R 4 is not hydrogen when R 1 is benzoyl, R 2 is methyl and R 3 is hydrogen.
R 4 is not hydrogen when R 1 is benzoyl, R 2 is ethyl and R 3 is a hydroxyl group. ) An aconitine compound represented by:
はエチル、R3は水酸基、アセチルオキシ又は水素、R4は
低級アルキル基又は水素を表す。但し、R1がベンゾイ
ル、R2がメチル又はエチル、R3が水酸基である場合はR4
は水素ではない。R1がベンゾイル、R2がメチル、R3が水
素である場合はR4は水素ではない。R1がアニソイル、R2
がエチル、R3が水酸基の場合はR4は水素ではない。) で表されるアコニチン系化合物を有効成分として含有す
る鎮痛・抗炎症剤。2. General formula (In the formula, R 1 represents benzoyl or anisoyl, R 2 represents methyl or ethyl, R 3 represents a hydroxyl group, acetyloxy or hydrogen, R 4 represents a lower alkyl group or hydrogen, provided that R 1 is benzoyl and R 2 is methyl. Or ethyl, R 4 when R 3 is a hydroxyl group
Is not hydrogen. R 4 is not hydrogen when R 1 is benzoyl, R 2 is methyl and R 3 is hydrogen. R 1 is Anisoyl, R 2
Is ethyl and R 3 is a hydroxyl group, R 4 is not hydrogen. ) An analgesic / anti-inflammatory agent containing an aconitine compound represented by
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62301221A JPH085866B2 (en) | 1987-11-29 | 1987-11-29 | Novel aconitine compounds and analgesic / anti-inflammatory agents |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62301221A JPH085866B2 (en) | 1987-11-29 | 1987-11-29 | Novel aconitine compounds and analgesic / anti-inflammatory agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH01143859A JPH01143859A (en) | 1989-06-06 |
| JPH085866B2 true JPH085866B2 (en) | 1996-01-24 |
Family
ID=17894241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62301221A Expired - Lifetime JPH085866B2 (en) | 1987-11-29 | 1987-11-29 | Novel aconitine compounds and analgesic / anti-inflammatory agents |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH085866B2 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5171691A (en) * | 1990-03-02 | 1992-12-15 | Chevron Research And Technology Company | Method for controlling multistage reforming process to give high octane barrel per calendar day throughput |
| WO1993006087A1 (en) * | 1991-09-27 | 1993-04-01 | Sanwa Shoyaku Kabushiki Kaisha | Novel aconitine compound and analgesic/antiinflammatory agent |
| EP0564648B1 (en) * | 1991-09-27 | 2000-05-03 | Sanwa Shoyaku Kabushiki Kaisha | Aconitine compound and analgesic/antiinflammatory agent |
| DE69132165T2 (en) * | 1991-09-27 | 2000-10-05 | Sanwa Shoyaku K.K., Utsunomiya | ACONITIN COMPOUND AND ANALGETIC / ANTI-INFLAMMATORY AGENT |
| US5496825A (en) * | 1991-09-27 | 1996-03-05 | Sanwa Shoyaku Kabushiki Kaisha | Aconitine compounds and analgesic/anti-inflammatory agent containing the same |
| EP0739882B1 (en) * | 1991-09-27 | 2001-06-13 | Sanwa Shoyaku Kabushiki Kaisha | Novel aconitine compounds and analgesic/anti-inflammatory agent containing the same |
| US5770604A (en) * | 1994-02-09 | 1998-06-23 | Sanwa Shoyaku Kabushiki Kaisha | Aconitine compound and an antipyretic/analgesic/anti-inflammatory agent |
-
1987
- 1987-11-29 JP JP62301221A patent/JPH085866B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH01143859A (en) | 1989-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2776292A1 (en) | Novel cephalotaxane derivatives with a side chain | |
| NZ270925A (en) | Process for conversion of ginkgolide c into ginkgolide b | |
| EP0080229B1 (en) | Salicylic derivatives of n-acetylcysteine | |
| HUT76333A (en) | Triterpene derivative and medicinal composition | |
| JPH085866B2 (en) | Novel aconitine compounds and analgesic / anti-inflammatory agents | |
| US4065458A (en) | Eburnamenine derivatives | |
| JP3466527B2 (en) | New aconitine compounds and analgesic / anti-inflammatory agents | |
| JP2732259B2 (en) | New aconitine compounds and analgesic / anti-inflammatory agents | |
| JPH0533955B2 (en) | ||
| CA1324134C (en) | Process for preparing (rs)-2-(2,3-dihydro-5-hydroxy-4,6, 7-trimethylbenzofuranyl) acetic acids and 2-(2,3-dihydro-5-acyloxy-4,6,7-trimethylbenzofuranyl) acetic acids and esters thereof, useful as mucoregulator and antihyschaemic drugs | |
| UHR et al. | The Structure of Acetomycin Spectroscopic Characterization and X-Ray Analysis of a Bromo Derivative | |
| EP0136831A2 (en) | Azahomoerythromycin B derivatives and intermediates thereof | |
| JPH085864B2 (en) | Novel aconitine compounds and analgesic / anti-inflammatory agents containing them as active ingredients | |
| JPH085862B2 (en) | Novel aconitine compounds and analgesic / anti-inflammatory agents containing them as active ingredients | |
| CN1052859A (en) | Structure and preparation method of 17-hydroxytriptolide and its analogs | |
| JP2000503666A (en) | Camptothecin isolated from Mappia foetida-backbone compounds and their use as synthons for novel pharmaceutical and therapeutic agents | |
| Senuma et al. | Highly Effective Resolution of 1, 3-Dibenzyl-6-hydroxy-3, 3a, 6, 6a-tetrahydro-1H-furo [3, 4-d] imidazole-2, 4-dione, an Intermediate for Biotin, with Optically Active Amines and Reutilizatin of the Unwanted Epimer | |
| JPH085865B2 (en) | Novel aconitine compounds and analgesic / anti-inflammatory agents containing them as active ingredients | |
| EP0564648B1 (en) | Aconitine compound and analgesic/antiinflammatory agent | |
| Chernyak et al. | Synthesis of carbohydrate-amino acid conjugates related to the capsular antigen K54 from Escherichia coli O6: K54: H10 and artificial antigens therefrom | |
| US4211706A (en) | 9-Deoxy-9α,6-nitrilo or 6,9α-imino-17,18-didehydro-PGF compounds | |
| JP2640239B2 (en) | Protostar-13 (17) ene-3,16-dione compound | |
| JP3999275B2 (en) | Diterbene compound having glutamate transporter inhibitory action | |
| US4895852A (en) | Antitumor alkaloids | |
| US4528372A (en) | N-Phthalidyl-5-fluorouracils |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |